Ultimate MCQ Mastery Instruction My goal is NOT to memorize questions. My goal is to become capable of answering any possible MCQ from any question bank (Marrow, Prepladder, Cerebellum, DAMS, Bhatia, Speed, INI-CET, FMGE, NEXT, university exams, or newly created questions) by understanding the underlying concepts. For every topic: Identify the fundamental concepts from which almost all MCQs are derived. Break each concept into first principles before moving to advanced applications. Explain why every fact is true instead of asking me to memorize it blindly. Teach every common and uncommon clinical presentation. Explain every important differential diagnosis with comparison tables. Cover every investigation, including indications, interpretation, limitations, and common exam traps. Explain every treatment with indications, contraindications, mechanisms, adverse effects, and guideline-based management. Highlight every commonly confused pair, look-alike disease, similar drug, similar investigation, and similar pathological finding. Show how a single concept can be tested in multiple different ways by examiners. Explain why each wrong option in an MCQ is incorrect and under what circumstances it could become correct. Generate progressively difficult questions: as per neet pg level and its style I want to prepare for CVS below given topics of medicine as per instructions given to you Ecg interpretation Basic cardiology topics Cardiac pharmacology topics Investigations topics Hypertension Arrhythmia topics

Reading File

Asking for Preferences

Finding Sources

Reading File

Finding Sources

Reading File

Here is your Module 1: Basic Cardiology - MCQ Mastery Guide for NEET PG.

MODULE 1: BASIC CARDIOLOGY

MCQ Mastery Guide - NEET PG Level

(Costanzo Physiology | Braunwald's Heart Disease | Gray's Anatomy | Fuster & Hurst's The Heart)

PART 1: CARDIAC CONDUCTION SYSTEM

The Core Concept - Why it Exists

The electrical system of the heart has ONE job: generate an action potential at the right rate, ensure atria contract BEFORE ventricles (with appropriate delay), and activate the entire ventricle rapidly and synchronously for efficient ejection.

The Principle: Automaticity + Conduction + Refractoriness = Coordinated pump function.

The Conduction System - Anatomy & Numbers (HIGH YIELD)

Structure	Location	Conduction Velocity	Rate of Discharge	Key Feature
SA Node	Junction of SVC + Right atrium (sulcus terminalis)	0.05 m/s	60-100/min	Primary pacemaker
AV Node	Near coronary sinus opening, near septal leaflet of tricuspid valve	0.01-0.05 m/s (slowest)	40-60/min	Creates AV delay (100 ms)
Bundle of His	Lower border of membranous IVS	1-2 m/s	40-60/min	Only AV electrical connection
Right Bundle Branch	Right side of IVS	2-4 m/s	20-40/min	Longer, thinner - more prone to block
Left Bundle Branch	Left side of IVS, fans into anterior + posterior fascicles	2-4 m/s	20-40/min	Divides into anterior + posterior
Purkinje Fibers	Subendocardial plexus	2-4 m/s (fastest)	20-40/min	Rapid ventricular activation

MCQ TRAP - AV Delay (100 ms) physiology:

The AV node deliberately slows conduction to ensure ventricles fill with blood from atria before contracting. Without this delay, ventricles would contract while still filling - reducing cardiac output.

Total conduction time: SA node to farthest ventricular point = 220 ms

SA Node - Why It's the Pacemaker

The Hierarchy Principle: SA node fires fastest (60-100/min), so it suppresses all lower pacemakers. If SA node fails:

AV node takes over at 40-60/min
Purkinje/ventricular cells take over at 20-40/min

This is called "overdrive suppression" - the faster pacemaker suppresses slower ones.

MCQ TRAP: "Which structure has the HIGHEST conduction velocity?" - Answer: Purkinje fibers (2-4 m/s). Do NOT confuse with the pacemaker function (SA node discharges fastest, Purkinje conducts fastest).

PART 2: CARDIAC ACTION POTENTIALS

Two Types - Know BOTH

Type 1: Fast Response (Atria, Ventricles, Purkinje) - 5 Phases

Phase	Name	Ion Responsible	Direction	Key Drug Effect
Phase 0	Rapid depolarization (upstroke)	Na+ IN (fast channels)	Inward	Blocked by Class I antiarrhythmics (quinidine, lidocaine)
Phase 1	Early rapid repolarization	K+ OUT (Ito current)	Outward	Creates notch on AP
Phase 2	Plateau	Ca2+ IN = K+ OUT	Balanced	Blocked by Class IV (verapamil, diltiazem)
Phase 3	Final repolarization	K+ OUT (IK current)	Outward	Blocked by Class III (amiodarone, sotalol)
Phase 4	Resting potential	K+ background current	Stable at -85 to -90 mV

Type 2: Slow Response (SA Node, AV Node) - No Fast Na+ channels

Phase	Ion	Key Difference
Phase 0	Ca2+ IN (slow channels)	Slower upstroke, smaller amplitude, slower conduction
Phase 4	Spontaneous depolarization (If = "funny" current - Na+/K+)	This IS automaticity - the reason SA/AV nodes are pacemakers
Resting potential	-50 to -65 mV (less negative than fast cells)

THE MOST TESTED CONCEPT:

Why does SA node have automaticity? - Because it has a spontaneously depolarizing Phase 4 (If current - slow inward Na+ current). The resting potential is not stable - it drifts toward threshold. When threshold is reached, an action potential fires. The slope of Phase 4 determines the HEART RATE.

Exam application:

Acetylcholine (vagal stimulation): decreases slope of Phase 4 → heart rate falls (negative chronotropy)
Sympathetic stimulation (noradrenaline): increases slope of Phase 4 → heart rate rises (positive chronotropy)
Beta-blockers: decrease slope of Phase 4 → slow heart rate

Refractory Periods - Tested Constantly

Period	Definition	Corresponds to
Absolute Refractory Period (ARP)	No stimulus, however strong, can generate AP	Phase 0 + Phase 1 + Phase 2 + early Phase 3 (cell cannot be reactivated)
Relative Refractory Period (RRP)	Only a supranormal stimulus can generate AP	Late Phase 3 (partial repolarization)
Supranormal Period	A weaker than normal stimulus can generate AP	End of Phase 3 (just before resting)

Refractoriness is linked to VOLTAGE, not time. The cell is refractory as long as the voltage is positive to -60 mV.

MCQ: A stimulus delivered during RRP produces: an action potential with slower upstroke (lower dV/dt) and slower conduction velocity - this can cause re-entry arrhythmias.

PART 3: CARDIAC CYCLE

7 Phases - The NEET PG Blueprint

Phase	What Happens	ECG	Valves	Heart Sound	Venous Pulse
A - Atrial Systole	Atria contract, final 30% ventricular filling	P wave	MV + TV open	S4 (not normal)	a wave
B - Isovolumetric Contraction (IVC)	Ventricles contract, all valves CLOSED, pressure rises, volume CONSTANT	QRS	MV closes	S1	c wave
C - Rapid Ejection	AoV opens, blood ejected, ventricular pressure peaks	ST segment	AoV opens	-	x descent
D - Reduced Ejection	Slower ejection, volume reaches minimum	T wave	-	-	-
E - Isovolumetric Relaxation (IVR)	Ventricles relax, all valves CLOSED, pressure falls, volume CONSTANT	After T wave	AoV closes	S2	-
F - Rapid Filling	Passive filling, MV opens, ventricle fills rapidly	-	MV opens	S3 (not normal in adults)	y descent
G - Reduced Filling (Diastasis)	Slow filling continues	-	-	-	v wave

The Most Commonly Confused Facts:

S1: Closure of MITRAL + TRICUSPID valves = Start of systole = During IVC S2: Closure of AORTIC + PULMONIC valves = Start of diastole = During IVR S3: Opening of mitral valve during rapid filling = Pathological in adults (heart failure, volume overload). NORMAL in children and pregnancy. S4: Atrial contraction into a stiff ventricle = Pathological = hypertension, hypertrophic cardiomyopathy, aortic stenosis

MCQ TRAP: "Which phase has ALL FOUR valves closed?" - BOTH IVC and IVR have all valves closed. Do not say "only one phase."

MCQ TRAP: "When does the aortic valve close?" - At the start of IVR, when aortic pressure falls below ventricular pressure (the dicrotic notch on aortic pressure trace = incisura = AoV closure).

Pressure Values - Know These

Location	Systolic	Diastolic
Left Ventricle	~120 mmHg	~0-5 mmHg
Aorta	~120 mmHg	80 mmHg
Left Atrium (Pulmonary Wedge)	-	~8-12 mmHg
Right Ventricle	~25 mmHg	~0-5 mmHg
Pulmonary Artery	~25 mmHg	10 mmHg
Right Atrium	-	0-8 mmHg

PART 4: JUGULAR VENOUS PULSE (JVP)

Waves and Their Causes

Wave/Descent	Cause	Corresponding ECG Event
a wave	Atrial contraction (RA systole)	After P wave
x descent	Atrial relaxation + tricuspid valve pulled down by ventricular contraction	During QRS-ST
c wave	Tricuspid valve bulging back into RA (small, often invisible)	During QRS
v wave	Venous return filling RA while tricuspid is closed	During T wave
y descent	Tricuspid valve opens, blood flows into RV	After T wave

Abnormal JVP Patterns - NEET PG Examiner's Favorites

Disease	JVP Finding	Mechanism
Tricuspid Regurgitation	Giant v wave (= cv wave, cannon v wave)	Blood regurgitates back into RA during systole
Tricuspid Stenosis / Right heart failure	Prominent a wave	RA contracts against resistance
Complete Heart Block	Cannon a waves (irregular)	Atrium contracts against closed tricuspid valve
Atrial Fibrillation	No a wave (only v wave)	No organized atrial contraction
Cardiac Tamponade	x descent preserved, y descent absent (Kussmaul absent)	Pericardial pressure prevents early diastolic RV filling
Constrictive Pericarditis	Both x and y descents prominent (M or W shape)	Rapid but then abruptly limited filling
Superior Vena Cava Obstruction	Raised JVP, non-pulsatile	Flow obstruction

MCQ TRAP:

Kussmaul's sign (JVP RISES on inspiration) = Constrictive pericarditis, restrictive cardiomyopathy, RV infarction
Normal = JVP FALLS on inspiration (increased venous return absorbed by compliant RV)
Tamponade = Kussmaul sign is ABSENT (JVP falls or unchanged on inspiration)

PART 5: FRANK-STARLING LAW

The Concept from First Principles

Why does it exist? To ensure that what enters the heart on the venous side equals what is ejected on the arterial side (venous return = cardiac output in steady state).

The Mechanism:

More venous return → more EDV (end-diastolic volume)
More EDV → more stretch of ventricular muscle fibers
More stretch → better overlap of actin-myosin cross-bridges → stronger contraction
Stronger contraction → more stroke volume

The Graph: Stroke volume (Y-axis) vs. EDV or Filling Pressure (X-axis) gives an upward-curving line.

How Contractility Shifts the Curve

Change	Effect on Curve	Examples
Positive inotropy	Curve SHIFTS UP (more SV for same EDV)	Digoxin, catecholamines, exercise
Negative inotropy	Curve SHIFTS DOWN (less SV for same EDV)	Beta-blockers, heart failure, myocardial ischemia
Increased preload (EDV)	Move ALONG the same curve (no shift)	Increased venous return, IV fluids
Increased afterload	Curve shifts DOWN (reduced SV)	Hypertension, aortic stenosis

MCQ TRAP: Preload vs. Contractility:

Giving IV fluids in heart failure = preload increase = moves along the curve
Giving digoxin = positive inotropy = shifts curve upward
These are DIFFERENT mechanisms, test them separately

Key Definitions (Always Tested)

Term	Formula	Normal Value
Stroke Volume (SV)	EDV - ESV	70 mL
Ejection Fraction (EF)	SV / EDV × 100	>55% (normal)
Cardiac Output (CO)	HR × SV	5 L/min
Cardiac Index (CI)	CO / BSA	2.4-4.0 L/min/m²
End-Diastolic Volume (EDV)	Volume at end of diastole	~140 mL
End-Systolic Volume (ESV)	Volume at end of systole	~70 mL
Preload	EDV (wall stress at end-diastole)	Determined by venous return
Afterload	Aortic pressure / wall stress during systole	Determined by BP and resistance

PART 6: CORONARY CIRCULATION (HIGH YIELD)

Blood Supply - Anatomy

Structure	Blood Supply
SA Node	Right coronary artery (RCA) in 55-60%; LCx in 40-45%
AV Node	RCA (posterior descending artery, PDA) in 90% of right-dominant circulations
Bundle of His	Dual supply (RCA + LAD)
Anterior wall of LV, anterior IVS	LAD (Left Anterior Descending)
Posterior wall of LV	RCA (right dominant) or LCx (left dominant)
Lateral wall of LV	LCx (Left Circumflex)
Right Ventricle	RCA
Posterior 1/3 of IVS	PDA (from RCA in right dominance)

Dominance

Right dominant (most common, ~85%): PDA arises from RCA Left dominant (~8%): PDA arises from LCx Co-dominant (~7%): Both contribute

Clinical application:

RCA occlusion → Inferior MI (leads II, III, aVF) + AV block (AV node ischemia)
LAD occlusion → Anterior MI (leads V1-V4) + LBBB risk
LCx occlusion → Lateral MI (leads I, aVL, V5-V6) - electrically silent on standard ECG

Coronary Physiology

The key principle: The heart extracts ~70% of O2 at rest (vs ~25% in other tissues). To increase O2 delivery, the heart must increase FLOW, not extraction.

Coronary blood flow = mainly DIASTOLIC - because:

During systole, myocardial contraction compresses intramyocardial vessels
Subendocardium is most vulnerable (highest wall stress, compressed first)
This is why diastolic hypotension is more dangerous for coronary flow than systolic

Autoregulation: Coronary flow stays constant over a perfusion pressure range of 60-140 mmHg. Below 60 mmHg → ischemia.

MCQ TRAP: "Which layer of the heart is most susceptible to ischemia?"

Subendocardium - highest wall stress, longest distance from epicardial arteries, compressed during systole, poorest autoregulation reserve

PART 7: HEART SOUNDS - DEEP ANALYSIS

S1 and S2 - The Core

S1: Mitral valve closes → aortic valve opens (transition from diastole to systole)

Loudest at apex (mitral area)
Corresponds to QRS on ECG (start of ventricular systole)

S2: Aortic valve closes → pulmonary valve closes (A2 before P2)

Loudest at base (aortic/pulmonic area)
A2P2 split: A2 comes before P2 because left ventricular pressure falls faster than RV pressure (lower pulmonary resistance)

Splitting of S2 - CRITICAL NEET PG TOPIC

Type	What It Means	Cause
Physiological splitting	Split widens on inspiration, disappears on expiration	Normal - inspiration increases RV filling → RV ejection delayed → P2 delayed
Wide splitting	Split present in both phases but wider in inspiration	RBBB (delayed P2), pulmonary stenosis, pulmonary hypertension (mild)
Fixed splitting	Split unchanged with respiration	ASD - equalization of left/right filling prevents respiratory variation
Paradoxical (reversed) splitting	Split on EXPIRATION, disappears on INSPIRATION	LBBB, severe aortic stenosis, HOCM - A2 is delayed, so P2 comes before A2. On inspiration, P2 moves back and "catches up" with A2, closing the split

The Rule: Fixed splitting = ASD until proven otherwise (in NEET PG context).

S3 and S4

Sound	Timing	Mechanism	Conditions
S3 (ventricular gallop)	Early diastole (after S2)	Rapid filling hits a non-compliant or dilated ventricle	Normal in children/pregnant women; Pathological in adults = LV failure, mitral regurgitation, volume overload
S4 (atrial gallop)	Late diastole (before S1)	Atrial contraction into a stiff ventricle	HTN, aortic stenosis, hypertrophic cardiomyopathy, acute MI - any cause of reduced compliance

S3 vs S4 memory: S3 = "Ken-tuc-KY" (lub-dub-ta), S4 = "TEN-nes-see" (ta-lub-dub)

MCQ TRAP: S4 is ABSENT in atrial fibrillation (no atrial contraction). This is a direct test of understanding mechanism.

PART 8: NEET PG STYLE MCQs - PROGRESSIVE DIFFICULTY

Level 1 - Foundation

Q1. The slowest conduction velocity in the cardiac conduction system is found in:

A. SA node
B. AV node
C. Bundle of His
D. Purkinje fibers

Answer: B - AV node (0.01-0.05 m/s)

Why wrong:

A: SA node is slow but not the slowest (~0.05 m/s); its KEY feature is DISCHARGE rate, not conduction
C: Bundle of His has intermediate velocity
D: Purkinje fibers have the FASTEST velocity (2-4 m/s)

When could D be correct? If the question asks "fastest conduction velocity" - answer would be D.

Q2. During isovolumetric contraction, which of the following is TRUE?

A. Aortic valve is open
B. Mitral valve is open
C. Ventricular volume is constant
D. Ventricular pressure is falling

Answer: C - Ventricular volume is constant

Why: All valves are closed during IVC. Ventricles contract, pressure rises, but no blood can leave (AoV still closed) or enter (MV just closed). So volume stays constant.

Why A is wrong: AoV opens only when LV pressure exceeds aortic pressure - that happens at the END of IVC, starting ejection phase. Why B is wrong: MV CLOSES at the START of IVC (= S1). Why D is wrong: Pressure is RISING during IVC (ventricles are actively contracting).

Q3. A patient in atrial fibrillation will have absence of which JVP wave?

A. v wave
B. y descent
C. a wave
D. x descent

Answer: C - a wave

Why: The a wave is produced by atrial contraction. In AF, there is no organized atrial contraction. The v wave and y descent persist because venous return still fills the RA and the tricuspid valve still opens.

Level 2 - Applied

Q4. A 65-year-old male with hypertension has an S4 gallop on examination. Which of the following best explains this finding?

A. Rapid ventricular filling in early diastole
B. Atrial contraction into a non-compliant ventricle
C. Mitral valve opening in diastole
D. Closure of the aortic valve during isovolumetric relaxation

Answer: B

Mechanism: LVH from hypertension reduces ventricular compliance. During atrial systole, when the atrium contracts to push blood into the stiff LV, vibrations are generated = S4.

Why A is wrong: That's S3 (rapid PASSIVE filling, not atrial contraction). Why C is wrong: Mitral valve opening produces an opening snap in mitral stenosis, not S4. Why D is wrong: That's S2.

Q5. In a patient with complete heart block on monitor, the JVP shows:

A. Absent a waves
B. Cannon a waves at irregular intervals
C. Prominent v waves
D. Absent y descent

Answer: B - Cannon a waves at irregular intervals

Mechanism: In complete heart block, atria and ventricles contract independently (AV dissociation). Occasionally, the atrium contracts while the tricuspid valve is CLOSED (because the ventricle has just fired). This forceful atrial contraction against a closed valve produces a large cannon a wave. Because it is asynchronous, it is IRREGULAR.

Contrast with: Cannon a waves in VT are regular if there is 1:1 retrograde VA conduction.

Q6. Which of the following drugs increases the slope of phase 4 depolarization in the SA node?

A. Metoprolol
B. Verapamil
C. Adrenaline
D. Digoxin (at therapeutic doses)

Answer: C - Adrenaline

Mechanism: Sympathetic stimulation (adrenaline/noradrenaline) → stimulates beta-1 receptors → increases If (funny current) and ICaL → steeper Phase 4 slope → faster depolarization → higher heart rate.

Why A is wrong: Metoprolol is a beta-blocker - it DECREASES the slope of Phase 4 (negative chronotropy). Why B is wrong: Verapamil blocks calcium channels - affects Phase 0 and plateau, but primarily slows AV conduction rather than SA node Phase 4 in therapeutic doses. Why D is wrong: Digoxin at therapeutic doses slows heart rate primarily via vagal (cholinergic) mechanism, and actually DECREASES Phase 4 slope in SA node.

Q7. Fixed splitting of S2 is a characteristic finding in:

A. Right bundle branch block
B. Atrial septal defect
C. Pulmonary hypertension
D. Aortic stenosis

Answer: B - Atrial septal defect

Why: In ASD, there is left-to-right shunt. During inspiration, increased venous return to RA is balanced by decreased left-to-right shunt (as RA pressure rises). During expiration, decreased venous return is balanced by increased left-to-right shunt. This keeps RV filling constant in both phases, so P2 timing is fixed relative to A2.

Why A is wrong: RBBB causes WIDE splitting (split present in both phases, widened in inspiration - not fixed). Why C is wrong: Pulmonary hypertension causes LOUD P2 and may cause wide splitting, but NOT fixed. Why D is wrong: Aortic stenosis delays A2 causing PARADOXICAL (reversed) splitting.

Level 3 - High Difficulty / Clinical Integration

Q8. A 55-year-old male collapses during exercise. ECG shows no P waves, QRS rate of 45/min with wide bizarre complexes. JVP shows regular cannon a waves. What is the most likely rhythm?

A. Atrial fibrillation with slow ventricular response
B. Complete heart block with ventricular escape rhythm
C. Junctional bradycardia
D. Ventricular tachycardia with VA conduction

Answer: B - Complete heart block with ventricular escape rhythm

Analysis:

No P waves visible (or dissociated from QRS)
Wide bizarre QRS = ventricular escape (idioventricular rhythm)
Rate 45/min = ventricular escape rate (20-40/min typical, but can be up to 45)
Regular cannon a waves = atria firing regularly, independently, occasionally against closed tricuspid (AV dissociation)

Why A is wrong: AF = no organized P waves, but QRS would be irregularly irregular (the question implies a pattern). Cannon a waves require ORGANIZED atrial activity. Why C is wrong: Junctional bradycardia has narrow QRS (conducted normally). Why D is wrong: VT rate is typically >100/min; VT with VA conduction would have retrograde P waves or regular cannon a waves but at a FAST rate.

Q9. Which of the following BEST describes the mechanism of paradoxical splitting of S2?

A. Delayed closure of the pulmonary valve due to increased RV filling
B. Delayed closure of the aortic valve due to prolonged LV ejection
C. Early closure of the pulmonary valve due to decreased RV filling
D. Simultaneous closure of both aortic and pulmonary valves

Answer: B

Mechanism: Normally A2 precedes P2. In paradoxical splitting, the aortic valve closes LATE (e.g., LBBB delays LV activation and prolongs LV ejection). Now P2 comes BEFORE A2. On inspiration, P2 moves later (away from A2 gap), narrowing or eliminating the split. On expiration, the two sounds separate.

Remember:

Normal: A2---P2 (wider on inspiration)
Paradoxical: P2---A2 on expiration, merges on inspiration

Q10. Preload is BEST measured clinically by:

A. Mean arterial pressure
B. Systemic vascular resistance
C. Pulmonary capillary wedge pressure (PCWP)
D. Ejection fraction

Answer: C - Pulmonary capillary wedge pressure

Why: PCWP reflects left atrial pressure, which reflects LV end-diastolic pressure (LVEDP), which is the best clinical surrogate of LV preload (EDV). Direct measurement of EDV is impractical clinically.

Why A is wrong: MAP primarily reflects afterload (peripheral resistance + CO). Why B is wrong: SVR = afterload. Why D is wrong: EF reflects contractility/systolic function, not preload.

QUICK-FIRE FACTS - MCQ One-Liners

"Pacemaker of the heart" = SA node (highest intrinsic rate)
"Fastest conducting tissue" = Purkinje fibers
"Slowest conducting tissue" = AV node
"Only electrical connection between atria and ventricles" = Bundle of His (AV bundle)
Phase 0 of SA node = Ca2+ influx (NOT Na+)
Phase 0 of ventricular cells = Na+ influx
Responsible for plateau (Phase 2) = Ca2+ in + K+ out (balanced)
Drug that abolishes phase 4 spontaneous depolarization = Acetylcholine (opens IKAch channel, hyperpolarizes SA node)
S3 in adult always pathological - heart failure, dilated cardiomyopathy
S4 absent in AF - no atrial contraction
Fixed splitting of S2 = ASD
Paradoxical splitting of S2 = LBBB, severe AS
Cannon a waves (irregular) = complete heart block
Prominent a wave in JVP = tricuspid stenosis, pulmonary stenosis, RVH
Absent a wave in JVP = atrial fibrillation
x and y descent prominent = constrictive pericarditis
y descent absent, x preserved = cardiac tamponade
Kussmaul sign present = constrictive pericarditis, restrictive CM, RV infarction
Kussmaul sign absent = cardiac tamponade
Ejection fraction <40% = systolic dysfunction (HFrEF)
EDV ↑ + EF normal = volume overload (preload excess)
EDV ↑ + EF ↓ = dilated cardiomyopathy/heart failure
Subendocardium = most vulnerable to ischemia
AV node blood supply = RCA (posterior descending artery) in 90%
SA node blood supply = RCA in 55-60%

COMMONLY CONFUSED PAIRS TABLE

Concept 1	Concept 2	Key Difference
SA node (fastest discharge)	Purkinje fibers (fastest conduction)	Rate of firing vs speed of conduction
S3 (early diastole, passive filling)	S4 (late diastole, atrial systole)	S3 = young/HF; S4 = stiff ventricle/HTN
IVC (pressure rising, volume constant)	IVR (pressure falling, volume constant)	Both have closed valves, opposite pressure trends
Fixed split S2 (ASD)	Wide split S2 (RBBB)	Fixed = unchanged with respiration
Paradoxical split (LBBB)	Wide split (RBBB)	Paradoxical = splits on EXPIRATION
Preload (EDV, PCWP)	Afterload (BP, SVR)	Preload = filling; Afterload = ejection resistance
Positive chronotropy (rate ↑)	Positive inotropy (contractility ↑)	Chrono = clock (rate); Ino = fiber (force)
Cannon a wave (irregular) in CHB	Cannon a wave (regular) in VT	Regularity helps distinguish
Kussmaul sign present (constrictive)	Kussmaul sign absent (tamponade)	Classic exam differentiator

This is Module 1 complete. The next modules are ready to build whenever you choose:

Module 2: ECG Interpretation - P wave, PR interval, QRS, ST-T changes, axis, bundle branch blocks, ischemia patterns
Module 3: Cardiac Pharmacology - Antiarrhythmics (Vaughan-Williams), beta-blockers, CCBs, ACE inhibitors, digoxin, anticoagulants
Module 4: Investigations - Echo, cardiac biomarkers (troponin, BNP, CK-MB), cardiac catheterization, stress testing, nuclear imaging
Module 5: Hypertension - Classification, pathophysiology, JNC/ESC guidelines, resistant HTN, secondary HTN, hypertensive urgency/emergency
Module 6: Arrhythmias - AF, flutter, SVT, VT, VF, WPW, bradyarrhythmias, heart blocks, treatment algorithms

Which module would you like next?

Start Module 2: ECG Interpretation with bundle branch blocks

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Here is Module 2: ECG Interpretation - MCQ Mastery Guide for NEET PG.

MODULE 2: ECG INTERPRETATION

Including Bundle Branch Blocks - MCQ Mastery Guide

NEET PG Level | Sources: Harrison's 22E, Braunwald's Heart Disease, Ganong's Physiology, Rosen's Emergency Medicine

PART 1: ECG BASICS - THE FOUNDATION LAYER

The Lead System - Why It Exists

An ECG records the same electrical activity from 12 different viewpoints (leads). A depolarization wave moving toward a lead's positive pole = positive deflection. Moving away = negative deflection.

Limb Leads (Frontal Plane)

Lead	Views	Positive Pole Direction
Lead I	Lateral wall	Left arm (+)
Lead II	Inferior + general	Left leg (+) - BEST for rhythm strip
Lead III	Inferior wall	Left leg (+) at different angle
aVR	Right heart/outflow	Right arm - always mostly negative
aVL	High lateral wall	Left arm up
aVF	Inferior wall	Left foot (+)

Inferior leads: II, III, aVF (think: foot leads = inferior) Lateral leads: I, aVL, V5, V6 Anterior/Septal leads: V1, V2, V3, V4

Normal ECG Intervals - MEMORIZE THESE

Parameter	Normal Range	Key Fact
Heart Rate	60-100/min	300/big square rule
P wave duration	<120 ms (3 small squares)	>120 ms = LAE/interatrial block
P wave amplitude	<2.5 mm	>2.5 mm = RAE (P-pulmonale)
PR interval	120-200 ms (0.12-0.20 s)	>200 ms = 1st degree AV block
QRS duration	<120 ms (<3 small squares)	≥120 ms = BBB or pre-excitation
QT interval	<440 ms men; <460 ms women	Correct for HR: QTc = QT/√RR
ST segment	Isoelectric (±1 mm)	Elevation or depression = pathological

Paper speed = 25 mm/s: 1 small square = 0.04 s (40 ms) | 1 big square = 0.20 s (200 ms)

Heart Rate Calculation

Regular rhythm: 300 ÷ number of large squares between R waves

1 large square = 300/min
2 large squares = 150/min
3 large squares = 100/min
4 large squares = 75/min
5 large squares = 60/min
6 large squares = 50/min

Mnemonic: "300, 150, 100, 75, 60, 50"

ECG Waves - Genesis from First Principles

P Wave

What it is: Atrial depolarization (RA first, then LA)
Normal: Positive in II (vector points toward left foot = inferior)
Negative in aVR always - this is normal
V1: Biphasic - initial positive (RA) then small negative (LA)

MCQ TRAP: If P waves are negative in leads II, III, aVF = ectopic atrial rhythm or junctional rhythm (retrograde P from AV node upward)

QRS Complex

What it is: Ventricular depolarization
Phase 1 (Septal): IVS depolarizes LEFT to RIGHT → small r in V1, small q in V6
Phase 2 (Ventricular): LV dominates, vector points LEFT and POSTERIOR → deep S in V1, tall R in V6

R-wave progression: Normally, R wave grows from V1 to V5-V6

Transition zone: Where R = S (normally V3 or V4)
Poor R-wave progression (PRWP): R wave fails to grow by V3 → suggests old anterior MI, LBBB, RVH, or misplaced leads

T Wave

What it is: Ventricular repolarization
Normal: Upright in all leads EXCEPT aVR (which is normally inverted) and V1 (which may be inverted normally)
T wave inversion in V1-V3: Can be normal in women; in men suggests anterior ischemia or right heart strain

U Wave

Small deflection after T wave
Most prominent in V2-V3
Prominent U wave = hypokalemia, bradycardia
Inverted U wave = ischemia, hypertension, LVH

Cardiac Axis - How to Determine

Normal axis = -30° to +90°

Quick Method - Look at Lead I and aVF

Lead I	aVF	Axis
Positive	Positive	NORMAL (most common)
Positive	Negative	LAD (Left Axis Deviation)
Negative	Positive	RAD (Right Axis Deviation)
Negative	Negative	Extreme axis (Northwest)

LAD = axis more negative than -30° RAD = axis more positive than +90°

Causes of Axis Deviation

LAD	RAD
Left anterior hemiblock (LAHB) - most common cause	Right ventricular hypertrophy
Left ventricular hypertrophy	Pulmonary hypertension
Inferior MI (old)	Lateral wall MI
LBBB	RBBB (mild RAD)
Wolff-Parkinson-White (left-sided pathway)	Left posterior hemiblock (LPHB)
Hyperkalemia	ASD (secundum)
Pregnancy, obesity (diaphragm elevation)	WPW (right-sided pathway)

MCQ TRAP: "Most common cause of LAD in adults" = Left anterior hemiblock (fascicular block) - not LVH (LVH causes LAD only sometimes, LAHB always causes LAD)

PART 2: BUNDLE BRANCH BLOCKS - DEEP ANALYSIS

Why BBBs Cause Wide QRS - The Core Mechanism

Normal activation: LBB and RBB conduct simultaneously → both ventricles activate at the same time → narrow QRS (LV and RV depolarize together)

With RBBB: Right bundle blocked → RV activated LATE (via slow cell-to-cell spread from LV) → terminal QRS vector points RIGHT and ANTERIOR (towards the blocked, delayed RV) → wide QRS

With LBBB: Left bundle blocked → LV activated LATE (via slow spread from RV) → terminal QRS vector points LEFT and POSTERIOR → wide QRS. ALSO - septal activation reversed (normally left to right, now right to left → no initial r in V1, no initial q in V6)

RBBB - Complete Diagnostic Guide

ECG Criteria (COMPLETE RBBB)

QRS ≥ 120 ms (≥ 0.12 s) - mandatory
rSR' in V1 or V2 ("rabbit ears" or "M pattern") - terminal R' = delayed RV
Wide, slurred S wave in I, V5, V6 - terminal rightward force
T wave inversion in V1, V2 - SECONDARY (expected, not ischemia)

Incomplete RBBB

QRS 110-120 ms (or even <110 ms)
rSR' in V1 present but narrow
Often a normal variant in young athletes
Can be seen in ASD (always check for ASD with iRBBB + RAD)

The RBBB Pattern Explained Lead-by-Lead

Lead	Pattern	Why
V1	rSR' (M-shaped, "rabbit ears")	Initial small r = normal septal activation; deep S = LV activation; R' = delayed RV activation
V6	qRS with wide S	Normal q (septal) + R (LV) + wide S (delayed RV going rightward away from V6)
Lead I	Wide slurred S	Terminal rightward force (delayed RV) goes away from Lead I

Clinical Associations of RBBB

Condition	Key Point
Normal variant	Can occur in healthy young people; RIGHT bundle is thinner, longer → more susceptible
ASD (septal defect)	iRBBB (incomplete) + RAD = primum ASD; iRBBB + normal/RAD = secundum ASD
Pulmonary embolism	NEW RBBB = acute right heart strain (classic "S1Q3T3" + RBBB)
Right ventricular hypertrophy	From any cause - cor pulmonale, pulmonary HTN
Myocarditis, Chagas disease	Damaged conduction tissue
Brugada syndrome	RBBB pattern + ST elevation in V1-V3 = Brugada pattern

LBBB - Complete Diagnostic Guide

ECG Criteria (COMPLETE LBBB)

QRS ≥ 120 ms - mandatory
Broad, notched (M-shaped) R wave in I, aVL, V5, V6 - "W" in right leads, "M" in left leads
Broad, deep QS or rS in V1, V2 - NO initial r wave (septal activation reversed)
No septal q waves in V5, V6 - normally there's a small q; LBBB abolishes it
T wave inversion in I, aVL, V5, V6 - SECONDARY (discordant T waves, expected)

The Key LBBB Concept: "WILLIAM MARROW" Mnemonic

Feature	LBBB	RBBB
V1 pattern	W (deep QS)	M (rSR')
V6 pattern	M (notched R)	W (qRS with S)

"WiLLiaM MaRRoW":

LBBB: W in V1, M in V6
RBBB: M in V1, W in V6

Reference Diagram from Braunwald/Harrison:

RBBB vs LBBB QRS-T patterns in V1 and V6

Direct from Harrison's 22E: Note the rSR' in V1 with RBBB and the T inversion (secondary, expected); versus the QS in V1 with LBBB and the broad R with inverted T in V6.

Clinical Associations of LBBB

Condition	Clinical Significance
Hypertensive heart disease	Most common cause - chronic pressure load
Coronary artery disease (ischemic)	New LBBB with chest pain = STEMI equivalent
Dilated cardiomyopathy	LBBB causes dyssynchrony (LV and RV contract at different times)
Aortic valve disease (stenosis)	LVH → LBBB progression
After TAVR (transcatheter aortic valve replacement)	High rate of new LBBB
Fibrosis of conduction system	Lenegre disease (primary fibrosis), Lev disease (secondary to valve calcification)

LBBB IS ALWAYS ABNORMAL (unlike RBBB which can be normal) - it always indicates underlying structural heart disease.

The LBBB Problem: Why ECG Is Uninterpretable

With LBBB:

ST-T changes are EXPECTED (secondary) - discordant T waves are normal in LBBB
Cannot diagnose LVH (voltage criteria don't apply)
Cannot assess for ischemia in the standard way
Cannot interpret ST segments normally

This is why: "New LBBB + chest pain = STEMI until proven otherwise" - the ECG cannot rule out MI.

PART 3: SGARBOSSA CRITERIA - DIAGNOSING MI IN LBBB

The Problem These Criteria Solve

When a patient has LBBB and chest pain, how do you find an MI if ST changes are always present in LBBB?

Original Sgarbossa Criteria (1996) - Score-Based

Criterion	Points	What It Means
ST elevation ≥1 mm CONCORDANT with QRS (both same direction)	5 points	Where QRS is positive (upright), ST should go DOWN in normal LBBB. ST going UP (same direction) = abnormal = MI
ST depression ≥1 mm in V1, V2, V3 CONCORDANT	3 points	V1-V3 have negative QRS in LBBB; ST should go up (discordant). ST going down (same direction) = abnormal
ST elevation ≥5 mm DISCORDANT (opposite to QRS)	2 points	Discordant ST is normal in LBBB, but if it's EXCESSIVELY large (≥5 mm), it suggests MI

Score ≥3 = high probability of acute MI (sensitivity ~36%, specificity ~96%)

Modified Sgarbossa Criteria (Smith 2012) - More Sensitive

Replaces the absolute "≥5 mm" criterion with a ratio:

ST elevation that is ≥25% of the preceding S wave depth (even if <5 mm) = suggestive of MI

This improves sensitivity while maintaining specificity.

MCQ Exam Tip:

"Concordant ST elevation ≥1 mm in LBBB" = strongest single criterion for MI (5 points)
The modification was: replacing absolute 5 mm discordance with ST/S ratio >0.25

PART 4: HEMIBLOCKS (FASCICULAR BLOCKS)

Anatomy Recap

The left bundle branch divides into:

Left Anterior Fascicle (LAF): Thinner, longer, single blood supply (LAD) → more susceptible to block
Left Posterior Fascicle (LPF): Thicker, shorter, dual blood supply (LAD + RCA) → more resistant to block

Left Anterior Hemiblock (LAHB) / Left Anterior Fascicular Block (LAFB)

Mechanism: LAF blocked → anterior-superior LV activated late via posterior fascicle → initial vector goes DOWN-RIGHT (inferior), then late vector swings UP-LEFT → LEFT axis deviation

ECG Criteria for LAHB:

Left axis deviation (LAD): axis more negative than -45° (some say -30°)
Small r, deep S in leads II, III, aVF (rS pattern in inferior leads)
Small q, tall R in leads I, aVL (qR pattern in lateral leads)
QRS duration normal or slightly prolonged (NOT ≥120 ms - hemiblocks alone don't cause wide QRS)
No other cause of LAD

Left Posterior Hemiblock (LPHB) / Left Posterior Fascicular Block (LPFB)

Mechanism: LPF blocked → posterior-inferior LV activated late → axis swings RIGHT

ECG Criteria for LPHB:

Right axis deviation (RAD): axis >+90° to +120°
Small r, deep S in I, aVL (rS in lateral leads)
Small q, tall R in II, III, aVF (qR in inferior leads)
Must exclude other causes of RAD (RVH, pulmonary hypertension, lateral MI)
LPHB is a diagnosis of exclusion (rare - posterior fascicle rarely blocks alone)

Feature	LAHB	LPHB
Axis	LAD (< -45°)	RAD (>+90°)
Lead I	qR	rS
Lead II/III/aVF	rS	qR
QRS duration	Normal	Normal
Clinical significance	Common, benign	Rare, serious - almost always associated with disease
Blood supply	Single (LAD)	Dual (LAD + RCA)

PART 5: BIFASCICULAR AND TRIFASCICULAR BLOCKS

Bifascicular Block

Definition: Block of 2 of the 3 fascicles simultaneously

Combination	ECG Appearance	Clinical Significance
RBBB + LAHB	Wide QRS (RBBB pattern) + LAD	Most common bifascicular block - common in CAD, hypertension
RBBB + LPHB	Wide QRS (RBBB pattern) + RAD	Less common but more serious
LBBB alone	Can be considered bifascicular (blocks both LAF + LPF)

Trifascicular Block

Definition: Dysfunction of all three fascicles (RBBB + both left fascicles)

ECG Appearance: This does NOT mean complete heart block on ECG. It means:

Option 1: RBBB + LAHB + prolonged PR (incomplete trifascicular block)
Option 2: RBBB + LPHB + prolonged PR (less common)
Complete trifascicular block = complete heart block (CHB)

MCQ TRAP: Trifascicular block on ECG = RBBB + fascicular block + long PR interval. This is NOT CHB yet - but it predicts progression to CHB.

Clinical Decision: Who Needs a Pacemaker?

Finding	Pacemaker Indication
Asymptomatic RBBB	NO
Asymptomatic LBBB	NO (but investigate cause)
Asymptomatic bifascicular block	NO
Bifascicular block + syncope/presyncope	YES (high risk of progression to CHB)
Bifascicular block + PR prolongation (trifascicular) + symptoms	YES
Alternating BBB (RBBB on one beat, LBBB on next)	YES - immediate pacemaker

PART 6: ECG IN SPECIFIC DISEASES - EXAM TRAPS

Pulmonary Embolism - S1Q3T3

Feature	Explanation
S wave in Lead I	Acute RV dilation → rightward axis shift
Q wave in Lead III	Rightward vector away from lead III
T wave inversion in Lead III	Right heart strain repolarization change
Sinus tachycardia	Most common ECG finding (>50%)
New RBBB	Acute right heart strain
Right axis deviation	RV overload
T-wave inversions V1-V4	Right ventricular strain

MCQ TRAP: S1Q3T3 has low sensitivity (~20%) for PE. Sinus tachycardia is the MOST COMMON ECG finding in PE. S1Q3T3 is specific but not sensitive.

LVH - Voltage Criteria

Most tested criterion: Sokolow-Lyon

SV1 + RV5 (or RV6) > 35 mm

Other criteria:

R in aVL > 11 mm (some books: >12 mm women, >13 mm men, 28 mm in older versions)
R in aVL > 20 mm in women, > 28 mm in men (Harrison's 22E)
Cornell criterion: SV3 + R aVL > 28 mm (men) or > 20 mm (women)

LVH on ECG also shows:

LAD (axis shift left)
Left atrial abnormality (P mitrale)
Strain pattern: ST depression + T inversion in V5, V6, I, aVL (lateral leads)

MCQ TRAP: "Best ECG criterion for LVH?" - The answer varies by exam. For NEET PG: Sokolow-Lyon (SV1 + RV5 >35 mm) is the most commonly tested. But remember it has low sensitivity (~50%) - echocardiography is more reliable.

Electrolyte Changes on ECG

Electrolyte	Changes
Hypokalemia	Flat/inverted T waves, prominent U waves, ST depression, long QU (looks like long QT)
Hyperkalemia	Peaked/tent T waves (earliest), wide QRS, flat P, sine wave pattern → VF
Hypocalcemia	Long QT (prolonged ST segment specifically)
Hypercalcemia	Short QT
Hypomagnesemia	Long QT, prominent U waves (similar to hypokalemia)

The Hyperkalemia Sequence (in order of severity):

Peaked T waves (K+ ~5.5-6.5)
Prolonged PR + wide QRS (K+ ~6.5-7.0)
P wave flattens/disappears (K+ ~7.0)
Sine wave pattern (K+ >8.0) → VF/asystole

Pericarditis vs STEMI - Classic Comparison

Feature	Acute Pericarditis	STEMI
ST elevation distribution	Diffuse (all leads except aVR)	Localized to territory (e.g., II/III/aVF)
Reciprocal ST depression	ABSENT	PRESENT (key differentiator)
PR depression	Present (pathognomonic)	Absent
aVR	ST depression, PR elevation	May have ST elevation
ST shape	Concave ("saddle-shaped")	Convex/straight ("tombstone")
Q waves	Absent	Develop later
Sequence	ST up → T inverses only after ST returns to baseline	T can invert while ST still elevated

MCQ TRAP: "Which finding helps distinguish pericarditis from MI?"

Reciprocal ST depression is ABSENT in pericarditis, PRESENT in MI
PR depression is characteristic of pericarditis (atrial injury)

PART 7: NEET PG MCQs - PROGRESSIVE DIFFICULTY

Level 1 - Foundation

Q1. In RBBB, the characteristic pattern seen in lead V1 is:

A. Wide, deep QS complex
B. Broad notched R wave (M pattern)
C. rSR' pattern (M or rabbit ears)
D. Tall R wave with ST depression

Answer: C - rSR' pattern

Why: In RBBB, septal activation is normal (small r), then LV dominates (deep S), then DELAYED RV activation produces a terminal R' wave directed rightward and anteriorly (toward V1). This gives the rSR' or "M" pattern in V1.

Why A is wrong: Wide deep QS (W pattern) in V1 = LBBB - exact opposite. Why B is wrong: Broad notched R wave is seen in V5/V6 in LBBB. Why D is wrong: Tall R in V1 with ST depression = RVH pattern; not RBBB.

Q2. The QRS duration in complete bundle branch block is:

A. 80-100 ms
B. 100-120 ms
C. ≥ 120 ms
D. > 200 ms

Answer: C - ≥ 120 ms

Why: "Complete" = ≥120 ms (3 small squares). "Incomplete" = 110-120 ms.

Why B is wrong: 100-120 ms = incomplete BBB (some use 110-120 ms specifically). NEET PG consistently uses ≥120 ms for complete BBB. Why D is wrong: PR interval is measured in seconds; a PR >200 ms = 1st degree block. QRS >200 ms would mean extremely slow conduction - not standard BBB definition.

Q3. Left anterior hemiblock causes:

A. Wide QRS with right axis deviation
B. Wide QRS with left axis deviation
C. Normal QRS with left axis deviation
D. Normal QRS with right axis deviation

Answer: C - Normal QRS with left axis deviation

Key principle: Hemiblocks block only ONE fascicle of the left bundle. The other fascicle + right bundle still conduct → QRS is NOT wide (does not reach 120 ms criterion). The AXIS shifts because ventricular activation is asymmetric. LAHB → LAD. LPHB → RAD.

Why A and B are wrong: Wide QRS = complete BBB (both fascicles on one side blocked). A hemiblock alone = narrow/normal QRS.

Level 2 - Applied

Q4. A 70-year-old presents with chest pain. ECG shows LBBB. Which of the following features on the ECG would be MOST suggestive of acute MI?

A. T wave inversion in V5, V6
B. ST elevation of 3 mm discordant with QRS in V2
C. ST elevation of 2 mm concordant with QRS in lead V5
D. QS complex in V1, V2

Answer: C - Concordant ST elevation

Sgarbossa criteria: Concordant ST changes (ST goes in SAME direction as QRS) are abnormal in LBBB and suggest MI. In V5, the QRS should be positive (R wave dominant) and the ST should be depressed/flat in normal LBBB. If ST is elevated in V5 (same direction as the R wave = concordant), this is a Sgarbossa criterion - score 5 points.

Why A is wrong: T inversion in V5/V6 is EXPECTED (secondary) in LBBB - the T wave is discordant with the terminal QRS in LBBB leads. Why B is wrong: 3 mm DISCORDANT ST elevation in V2 - discordance is expected in LBBB. It would need to be ≥5 mm discordant (original criteria) or ≥25% of S wave (modified) to count. Why D is wrong: QS in V1/V2 is the expected NORMAL finding in LBBB (reversed septal activation).

Q5. A 55-year-old with no cardiac history has an ECG showing RBBB and left axis deviation. What is the MOST likely diagnosis?

A. Complete heart block
B. Left posterior hemiblock
C. Bifascicular block
D. Trifascicular block

Answer: C - Bifascicular block

Anatomy: RBBB (right bundle blocked) + LAD (left anterior fascicle blocked) = 2 of 3 fascicles blocked = bifascicular block. This is the most common bifascicular pattern.

Why A is wrong: CHB would show complete AV dissociation with slow escape rhythm; QRS may be wide but the pattern here is RBBB + LAD. Why B is wrong: LPHB causes RAD, not LAD. Why D is wrong: Trifascicular block = RBBB + fascicular block + prolonged PR (third fascicle partially conducting slowly). No mention of PR prolongation here.

Q6. Which of the following best distinguishes pericarditis from STEMI on ECG?

A. Tall R wave in precordial leads
B. Presence of reciprocal ST depression
C. Presence of diffuse ST elevation
D. ST elevation in limb leads

Answer: B - Presence of reciprocal ST depression

Mechanism: In STEMI, the infarcting territory has ST elevation, while the opposite territory shows mirror-image ST depression (reciprocal changes). In pericarditis, inflammation is global - there is no ischemic territory and thus NO RECIPROCAL CHANGES.

Why C is wrong: Diffuse ST elevation is actually MORE typical of pericarditis (not MI). This option would make pericarditis look like the answer, but the question asks what distinguishes them - and the answer is what STEMI has that pericarditis does NOT. Why D is wrong: Both can show ST elevation in limb leads.

Q7. In a patient with hypokalemia, the EARLIEST ECG change is:

A. Wide QRS
B. Peaked T waves
C. Prominent U waves / T wave flattening
D. Prolonged PR interval

Answer: C - Prominent U waves / T wave flattening

Mechanism: Hypokalemia slows ventricular repolarization (phase 3), prolonging the action potential and producing a prominent U wave (reflects late repolarization of Purkinje fibers). T waves flatten. The QTU interval appears prolonged.

Why B is wrong: Peaked T waves = hyperKALEMia, not hypokalemia. This is a classic reversal trap.

Level 3 - High Difficulty / Clinical Integration

Q8. A 45-year-old man collapses in the street. ECG shows: wide QRS >120 ms, rSR' in V1, S wave in V5/V6, ST elevation of 2 mm in V1-V3 with coved (concave upward toward J-point then descending) morphology. He has NO electrolyte abnormality, NO fever, and normal coronary arteries on cath. What is the diagnosis?

A. Acute anterior STEMI
B. Right bundle branch block with anteroseptal ischemia
C. Brugada syndrome (Type 1 pattern)
D. Pulmonary embolism with right heart strain

Answer: C - Brugada syndrome Type 1

Criteria for Type 1 Brugada:

Coved-type ST elevation (≥2 mm) in V1-V3 (J-point elevation followed by descending ST into negative T wave)
RBBB pattern (rSR' in V1)
Normal coronary arteries (not ischemia)
Typical presentation: syncope/sudden death in young males

Brugada Types:

Type 1 (Coved): ≥2 mm J elevation, descending ST, negative T - DIAGNOSTIC
Type 2 (Saddleback): ≥2 mm J elevation, saddleback ST, positive T - NOT diagnostic alone
Type 3: <2 mm - NOT diagnostic

Why A is wrong: STEMI would have reciprocal changes and respond to PCI. Brugada has normal coronaries. Why D is wrong: PE causes S1Q3T3 and sinus tachycardia; the J-point elevation with coved pattern is specific for Brugada.

Q9. A patient with RBBB and LAHB develops prolonged PR interval (260 ms) and complains of near-syncope. The NEXT BEST step is:

A. Reassure and discharge
B. Refer for EP study and prophylactic pacemaker
C. Start metoprolol
D. Repeat ECG in 6 months

Answer: B - EP study / pacemaker

Reasoning: This patient has trifascicular block (RBBB + LAHB = 2 fascicles blocked, + PR prolongation = the third fascicle [LPF or the AV node/His] conducting slowly). WITH symptoms (near-syncope), this is a Class I indication for pacemaker implantation - high risk of progressing to complete heart block.

Why C is wrong: Beta-blockers would WORSEN AV conduction and could precipitate CHB. Why A is wrong: Symptomatic trifascicular block is not benign.

Q10. A patient has ECG showing: SV1 = 15 mm, RV5 = 25 mm, T wave inversion in V5/V6, left axis deviation, and bifid P waves in lead II. What is the MOST COMPLETE diagnosis?

A. RBBB with LAHB
B. LVH with strain pattern + Left atrial enlargement
C. Anterior STEMI
D. Dilated cardiomyopathy

Answer: B - LVH with strain pattern + LAE

Analysis of each finding:

SV1 (15) + RV5 (25) = 40 mm > 35 mm = Sokolow-Lyon criterion for LVH ✓
T inversion in V5/V6 = strain pattern (secondary repolarization change from LVH) ✓
LAD = associated with LVH ✓
Bifid (notched) P waves in lead II = P mitrale = Left atrial enlargement (LA takes longer to depolarize, producing wide, notched P) ✓

Why A is wrong: RBBB would show rSR' in V1 and wide QRS - not described. Why C is wrong: STEMI would show ST elevation (not T inversion) in the acute phase; and would not explain the P wave change.

QUICK-FIRE MCQ ONE-LINERS

RBBB pattern in V1 = rSR' ("M" or "rabbit ears")
LBBB pattern in V1 = QS or rS (W pattern)
"WiLLiaM MaRRoW" = LBBB: W in V1, M in V6; RBBB: M in V1, W in V6
LBBB is always pathological - must find cause
RBBB can be normal variant (especially incomplete RBBB)
New LBBB + chest pain = treat as STEMI
Sgarbossa #1 criterion = concordant ST elevation ≥1 mm = 5 points (most specific)
Sgarbossa modified = ST/S wave ratio >0.25 replaces the 5 mm discordant criterion
LAHB = LAD + qR in I/aVL + rS in II/III/aVF + normal QRS width
LPHB = RAD + qR in II/III/aVF + rS in I/aVL + diagnosis of exclusion
Bifascicular block = RBBB + LAHB (most common) or RBBB + LPHB
Trifascicular block = Bifascicular + long PR (not CHB yet)
Alternating BBB = immediate pacemaker needed
S1Q3T3 = PE (low sensitivity ~20%)
Brugada Type 1 = coved ST ≥2 mm in V1-V3 + RBBB pattern - diagnostic
Peaked T waves = hyperkalemia (earliest change)
Prominent U waves = hypokalemia
Short QT = hypercalcemia
Long QT = hypocalcemia, hypokalemia, hypomagnesemia, drugs
Diffuse ST elevation + PR depression = pericarditis
Reciprocal ST depression = present in MI, absent in pericarditis
Fixed splitting S2 + iRBBB = ASD
Sokolow-Lyon criterion = SV1 + RV5 >35 mm = LVH
P mitrale = broad notched P in II; P terminal force in V1 <-40 ms·mm = LAE
P pulmonale = peaked P >2.5 mm in II = RAE

COMMONLY CONFUSED PAIRS

Concept 1	Concept 2	The Differentiator
RBBB (rSR' in V1)	LBBB (QS in V1)	"WiLLiaM MaRRoW" rule
LAHB (LAD, normal QRS)	LBBB (LAD, wide QRS)	LAHB = narrow QRS; LBBB = ≥120 ms
LPHB (RAD)	RVH (RAD)	LPHB = tall R in II/III/aVF with qR pattern; RVH = tall R in V1
Bifascicular block (RBBB+LAHB)	Trifascicular block (+long PR)	Addition of PR prolongation
Hyperkalemia (peaked T)	Hypokalemia (flat T + U wave)	"K-peak" = hyperK; "U-wave" = hypoK
Pericarditis (no reciprocal)	STEMI (reciprocal present)	Reciprocal ST depression = STEMI
Brugada Type 1 (coved)	Brugada Type 2 (saddleback)	Only Type 1 is diagnostic
Concordant ST (Sgarbossa +)	Discordant ST (normal in LBBB)	Concordant = SAME direction as QRS = abnormal
Incomplete RBBB (normal)	Complete RBBB (≥120 ms)	110-119 ms = incomplete; ≥120 ms = complete
S1Q3T3 (PE pattern)	Inferior MI (Q waves in II/III/aVF)	PE = Q only in III (not II); MI = Q in II AND III/aVF

Module 2 complete. Ready to build the next one whenever you choose:

Module 3: Cardiac Pharmacology - Antiarrhythmics (all 4 Vaughan-Williams classes), beta-blockers, CCBs, digoxin, ACE inhibitors/ARBs, nitrates, anticoagulants, antiplatelets - mechanisms, adverse effects, contraindications, every drug-drug interaction
Module 4: Investigations - Echo (M-mode, 2D, Doppler), cardiac biomarkers (troponin evolution, BNP, CK-MB), stress testing, catheterization, nuclear imaging
Module 5: Hypertension - JNC 8 vs ESC 2023 guidelines, resistant HTN, hypertensive emergencies, secondary HTN workup
Module 6: Arrhythmias - AF/flutter, SVT types, WPW, VT, VF, all heart blocks, treatment algorithms

Which module is next?

Create a comparison table of all cardiac conduction abnormalities with ECG findings

Finding Sources

Reading File

Finding Sources

Reading File

All the data I need is now in context. Here is the complete, authoritative comparison table.

CARDIAC CONDUCTION ABNORMALITIES

Complete Comparison Table - NEET PG MCQ Reference

Source: Harrison's 22E | Fuster & Hurst's The Heart | Braunwald's Heart Disease | Ganong's Physiology

TABLE 1: SA NODE DISORDERS

Disorder	ECG Findings	Rate	P Wave	Key Feature	Causes	Pacemaker?
Sinus Bradycardia	Normal sinus P → QRS, PR normal, Rate <60/min	<60/min	Normal morphology, upright in II	Every P followed by QRS; just slow	Vagal tone, athletes, hypothyroidism, drugs (beta-blockers, digoxin, CCBs), inferior MI	Only if symptomatic
Sinus Tachycardia	Normal sinus P → QRS, Rate >100/min	>100/min	Normal morphology	Rate increases/decreases gradually; cannot cardiovert	Fever, pain, PE, hypovolemia, anaemia, anxiety, hyperthyroidism, drugs	Treat cause
Sinus Arrhythmia	Normal P waves, PR normal; R-R intervals vary with respiration	Variable	Normal	R-R shortens on inspiration (vagal withdrawal)	Normal variant in young	No
Sinus Arrest / Pause	Absent P wave; pause not multiple of P-P cycle	-	Missing	Pause duration is NOT a multiple of PP interval (distinguishes from SA exit block)	Vagal surge, sick sinus, drugs	Yes if symptomatic + recurrent
SA Exit Block Type I (Wenckebach)	Progressive shortening of PP interval before a pause; pause < 2× PP	Variable	Normal between pauses	PP interval shortens before dropped P (like Wenckebach of AV) - rarely recognized	Sick sinus syndrome	Yes if symptomatic
SA Exit Block Type II	Sudden pause = EXACT multiple of PP interval (2× or 3× PP)	Variable	Normal between pauses	Pause = EXACT multiple of PP cycle (distinguishes from sinus arrest)	Sick sinus syndrome, drugs, ischemia	Yes if symptomatic
Sick Sinus Syndrome (SSS)	Combination: sinus bradycardia + pauses + tachycardia-bradycardia syndrome	Variable	Abnormal timing	Tachy-Brady syndrome: paroxysmal AF/SVT followed by long pause on termination	Idiopathic fibrosis, ischemia, infiltrative disease	Yes - most common indication for pacemaker in the US (42-60% of implants)

TABLE 2: AV NODE BLOCKS (SA to AV Junction)

Block	Degree	ECG Findings	PR Interval	P:QRS Ratio	QRS Width	Location of Block	Reversible?	Pacemaker?
1st Degree AV Block	1st	ALL P waves conducted; PR prolonged >200 ms (>5 small squares)	Fixed, >200 ms	1:1	Normal (usually)	AV node (90%); rarely His-Purkinje	Often (vagal, drugs, inferior MI)	No - benign
2nd Degree - Mobitz I (Wenckebach)	2nd	PR progressively lengthens → one P dropped → reset. Grouped beating. RR shortens.	Progressive increase then reset	Variable: 3:2, 4:3, 5:4	Normal (usually narrow)	AV node (supranodal, nodal)	Often reversible (inferior MI, drugs)	Usually NO (unless symptomatic)
2nd Degree - Mobitz II	2nd	PR constant → one P suddenly drops (no warning)	Fixed, constant	Variable: 2:1, 3:1, 4:1	Usually WIDE (BBB almost always present)	Infranodal (His-Purkinje) - below the His bundle	Rarely reversible	YES - always, even if asymptomatic
2:1 AV Block	2nd	Every other P blocked; can't distinguish Mobitz I from II from ECG alone	Fixed	2:1	Narrow = likely nodal (Mobitz I); Wide = likely infranodal (Mobitz II)	Determined by QRS width + PR duration	-	Depends on type (Mobitz II = pacemaker)
High-Grade AV Block	2nd/3rd	2+ consecutive P waves blocked; some conduction preserved	Variable	3:1 or more	May be wide	Infranodal (usually)	Rarely	YES - pacemaker required
3rd Degree (Complete) AV Block	3rd	Complete AV dissociation: P and QRS independent; Atrial rate > Ventricular rate	No relationship (P and QRS unrelated)	P waves unrelated to QRS	Narrow (junctional escape at 40-60/min) if block at AV node; Wide (ventricular escape at 20-40/min) if His-Purkinje block	AV node OR infranodal	Rarely (if inferior MI - may recover)	YES - always (except reversible causes)

TABLE 3: CRITICAL MOBITZ I vs MOBITZ II COMPARISON (Most Tested)

Feature	Mobitz I (Wenckebach)	Mobitz II
PR interval behavior	Progressively LENGTHENS	Stays CONSTANT
PR before dropped beat	Longest PR in the cycle	Same as all others
PR after dropped beat	SHORTEST (resets)	Same as all others
RR intervals	Progressively SHORTEN before pause	Constant
QRS width	Usually NARROW	Usually WIDE (BBB present)
Site of block	AV Node (above His)	Infranodal (below His)
Escape rhythm if progresses	Junctional (reliable, 40-60/min)	Ventricular (unreliable, 20-40/min)
Risk of progression to CHB	LOW	HIGH - unpredictable, sudden
Haemodynamic stability	Usually stable	Unstable - can cause syncope/sudden death
Effect of atropine	IMPROVES (speeds AV node)	May WORSEN (faster atrial rate → more blocked beats)
Effect of exercise	IMPROVES	WORSENS
Associated conditions	Inferior MI, digoxin toxicity, athletic heart, vagal tone	Anterior MI, Lenegre/Lev disease, cardiomyopathy
Pacemaker needed?	Usually NO (unless symptomatic)	YES - always, even if asymptomatic
JVP finding	Intermittent dropped beat pattern	Dropped beat pattern

TABLE 4: INTRAVENTRICULAR CONDUCTION DEFECTS

Disorder	QRS Width	V1 Pattern	V6/I/aVL Pattern	Axis	T Wave	Key Rule
Normal	<120 ms	rS or rSr' (small r, dominant S)	qR or Rs (small q, tall R)	Normal (-30° to +90°)	Upright in I, II, V4-V6	Baseline
Incomplete RBBB	110-119 ms	rSr' or rsR'	Small S wave	Normal or slight RAD	Upright	Normal variant in young/athletes
Complete RBBB	≥120 ms	rSR' (M/rabbit ears)	qRS with wide slurred S	Normal or slight RAD	Inverted V1-V2 (secondary - EXPECTED)	"MaRRoW" - M in V1
Incomplete LBBB	110-119 ms	rS, no Q in V5/V6	Notched broad R	Normal or LAD	-	Treat like LBBB
Complete LBBB	≥120 ms	QS or rS (W shape)	Broad notched R (M shape)	Normal or LAD	Inverted I, aVL, V5-V6 (secondary - EXPECTED)	"WiLLiaM" - W in V1. ALWAYS pathological
LAHB (Left Anterior Hemiblock)	Normal (<120 ms)	No specific change	qR in I, aVL	LAD < -45°	Normal	LAD + rS in inferior leads + narrow QRS
LPHB (Left Posterior Hemiblock)	Normal (<120 ms)	No specific change	rS in I, aVL; qR in II/III/aVF	RAD >+90°	Normal	RAD + diagnosis of exclusion (exclude RVH)
Bifascicular Block (RBBB + LAHB)	≥120 ms	rSR'	qRS with S; qR in I/aVL	LAD	Inverted V1-V2 (secondary)	Most common bifascicular pattern
Bifascicular Block (RBBB + LPHB)	≥120 ms	rSR'	qRS with S; rS in I	RAD	Inverted V1-V2	Less common; more serious
Trifascicular Block	≥120 ms	rSR' (bifascicular pattern)	As above	As above	As above	Bifascicular ECG + PR prolonged (>200 ms)
Alternating BBB	Variable	Alternates rSR' / QS	Changes beat to beat	Variable	Changes	Emergency - immediate pacemaker

TABLE 5: AV DISSOCIATION vs COMPLETE HEART BLOCK (Commonly Confused)

Feature	AV Dissociation	Complete Heart Block (3rd Degree)
Definition	Atria and ventricles controlled independently for any reason	Complete failure of AV conduction - a specific type of AV dissociation
Atrial rate vs Ventricular rate	Ventricular rate ≥ atrial rate (ventricle has taken over or is equal)	Atrial rate > ventricular rate (atria faster, ventricles slow)
Is AV block present?	Not necessarily - may be due to accelerated junctional/ventricular rhythm or sinus bradycardia	Yes - absolute block present
AV dissociation implies CHB?	No - AV dissociation can occur WITHOUT block (isorhythmic, VT with retrograde block)	Yes - CHB always has AV dissociation
CHB implies AV dissociation?	Yes - CHB is always a form of AV dissociation	-
Capture beats	May occur (if sinus impulse finds non-refractory ventricle)	No capture beats possible
Fusion beats	May occur	Rarely possible
Causes	VT, junctional tachycardia, sinus bradycardia, isorhythmic	Inferior MI, anterior MI, Lenegre disease, infiltration (sarcoid, amyloid), congenital
MCQ Rule	"All CHB has AV dissociation, but not all AV dissociation is CHB"	-

TABLE 6: COMPLETE HEART BLOCK - ESCAPE RHYTHM COMPARISON

Feature	Junctional Escape (AV Node Block)	Ventricular Escape (His-Purkinje Block)
QRS morphology	NARROW (normal His-Purkinje conduction)	WIDE, bizarre (ventricular activation cell-to-cell)
Rate	40-60/min	20-40/min
Reliability	More reliable	UNRELIABLE - can suddenly stop (Adams-Stokes attacks)
Haemodynamics	More stable	More unstable
Location of block	AV node itself	Infranodal (His-Purkinje system)
Association	Inferior MI, AV nodal disease, congenital	Anterior MI, Lenegre/Lev disease, bilateral BBB
Atropine response	May respond (AV node has autonomic innervation)	Does NOT respond (His-Purkinje has no autonomic innervation)
JVP	Cannon a waves (irregular)	Cannon a waves (irregular)
Pacemaker	Yes - required	Yes - urgent

TABLE 7: CONGENITAL vs ACQUIRED COMPLETE HEART BLOCK

Feature	Congenital CHB	Acquired CHB
Cause	Maternal anti-Ro/anti-La antibodies (neonatal lupus), structural heart defects	MI (inferior or anterior), Lenegre/Lev fibrosis, sarcoid, amyloid, Lyme disease, drugs, post-surgical
Block level	AV node	AV node (inferior MI) or His-Purkinje (anterior MI)
Escape rate	Relatively fast junctional (~50/min)	Slower, less reliable
QRS	Narrow	Wide (if infranodal)
Prognosis	Better - junctional escape reliable	Worse - unpredictable sudden cardiac death risk
Pacemaker	Required if symptomatic or rate <50/min	Usually required; anterior MI CHB = always

TABLE 8: CAUSES OF EACH CONDUCTION ABNORMALITY (MCQ Associations)

Conduction Defect	Classic Causes to Remember
1st Degree AV Block	Inferior MI, digoxin toxicity, beta-blockers, CCBs, high vagal tone, myocarditis, Lyme disease
Mobitz I (Wenckebach)	Inferior MI (AV nodal artery = RCA in 90%), digoxin toxicity, athletic heart, post-cardiac surgery, myocarditis
Mobitz II	Anterior MI (septal perforators from LAD supply His-Purkinje), Lenegre disease, Lev disease, cardiomyopathy, myocarditis
Complete Heart Block	Anterior MI (infranodal, emergency), inferior MI (nodal, often reversible), Lenegre/Lev, sarcoidosis, amyloidosis, Lyme disease, congenital (maternal anti-Ro), post-TAVR, post-cardiac surgery
RBBB	Normal variant, ASD, pulmonary embolism, RVH, Brugada syndrome, myocarditis, Chagas disease, ischemia
LBBB	Hypertensive heart disease, CAD, dilated cardiomyopathy, aortic stenosis, post-TAVR, Lenegre/Lev
LAHB	Hypertension (most common), inferior MI, cardiomyopathy, fibrosis
LPHB	Must exclude RVH; suggests serious disease - inferior MI, diffuse fibrosis
Bifascicular block	CAD, hypertension, cardiomyopathy

TABLE 9: PACEMAKER INDICATIONS - NEET PG QUICK REFERENCE

Condition	Pacemaker?	Notes
Asymptomatic sinus bradycardia	NO	Unless rate <40/min at rest or on exertion
Sick sinus syndrome + symptoms	YES	Most common pacemaker indication in US
1st degree AV block	NO	Benign; no pacing needed
Mobitz I (asymptomatic)	NO	Monitor
Mobitz I (symptomatic)	YES
Mobitz II (any)	YES - ALWAYS	Even if asymptomatic - high risk of sudden CHB
High-grade AV block	YES - ALWAYS
CHB (any, acquired)	YES - ALWAYS	Unless reversible cause (inferior MI - wait 5 days)
Bifascicular block (asymptomatic)	NO	Low risk of progression
Bifascicular block + syncope	YES	High suspicion of intermittent CHB
Trifascicular block + syncope	YES
Alternating BBB	YES - EMERGENCY	Immediate implant
Post-anterior MI with CHB	YES - ALWAYS	Does not spontaneously recover
Post-inferior MI with CHB	Usually temporary - observe	Often reversible; permanent if persists >5-7 days
Congenital CHB + rate <50/min	YES
LBBB in heart failure	CRT (biventricular pacemaker)	Not conventional pacemaker - resynchronization

TABLE 10: ECG DIAGNOSIS FLOWCHART SUMMARY

STEP 1: Is QRS WIDE (≥120 ms)?
  YES → Bundle Branch Block or Pre-excitation (WPW) or Ventricular rhythm
  NO  → Narrow complex rhythm → AV block, SA disorder, or normal

STEP 2 (if wide): V1 pattern?
  rSR' (M) → RBBB
  QS/rS (W) → LBBB
  Delta wave + short PR → WPW

STEP 3 (if narrow): Are all P waves conducted?
  YES (but PR >200 ms) → 1st Degree AV Block
  NO (some dropped) → 2nd Degree AV Block
  NO (P and QRS unrelated) → 3rd Degree (CHB) or AV Dissociation

STEP 4 (if 2nd degree): Does PR change before dropped beat?
  PR LENGTHENS → Mobitz I (Wenckebach) → AV node → usually no pacemaker
  PR CONSTANT  → Mobitz II → Infranodal → ALWAYS pacemaker

STEP 5 (if P absent): Is it SA node problem?
  P absent, pause = multiple of PP → SA exit block Type II
  P absent, pause ≠ multiple of PP → Sinus arrest
  No P at all → Junctional rhythm, AF, or atrial standstill

QUICK-FIRE ONE-LINERS FOR NEET PG

"PR lengthens till a beat drops = Wenckebach = usually benign"
"PR stays constant, beat suddenly drops = Mobitz II = always pacemaker"
"CHB: atrial rate > ventricular rate" | "AV dissociation: ventricular rate ≥ atrial rate"
"All CHB is AV dissociation, not all AV dissociation is CHB"
"Narrow escape in CHB = AV node block (reliable, 40-60)" | "Wide escape = infranodal (unreliable, 20-40)"
"Atropine works on AV node (autonomically innervated), NOT on His-Purkinje"
"Inferior MI → Mobitz I or CHB at AV node (usually reversible)"
"Anterior MI → Mobitz II or CHB at His-Purkinje (NEVER reversible = always pacemaker)"
"Mobitz II + asymptomatic = pacemaker anyway" (most tested pacemaker MCQ)
"Alternating BBB = emergency pacemaker" (highest urgency)
"LBBB always pathological; RBBB can be normal variant"
"rSR' in V1 = RBBB (MaRRoW); QS in V1 = LBBB (WiLLiaM)"
"Hemiblock = narrow QRS + axis deviation only"
"Bifascicular = wide QRS + axis deviation"
"Trifascicular = bifascicular + long PR"
"Most common cause of LAD = LAHB"
"LPHB = diagnosis of exclusion (always exclude RVH first)"
"Sick sinus syndrome = most common pacemaker indication in US"
"SA exit block Type II: pause = exact multiple of PP interval"
"Sinus arrest: pause ≠ multiple of PP interval"
"Congenital CHB → maternal anti-Ro/anti-La antibodies (neonatal lupus)"
"Lenegre disease = idiopathic fibrosis of conduction system (primary)"
"Lev disease = fibrosis from adjacent calcified valves (secondary)"
"Post-TAVR: high rate of new LBBB (conduction tissue adjacent to prosthesis)"
"CRT (biventricular pacing) in LBBB + heart failure + EF <35%" - not standard pacemaker

The full spectrum from SA node to ventricular conduction defects is covered. Ready for the next module whenever you want - Cardiac Pharmacology, Hypertension, Arrhythmias, or Investigations.

Create Module 3: Cardiac Pharmacology with all drug classes & mechanisms

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Here is the full Module 3: Cardiac Pharmacology - MCQ Mastery Guide for NEET PG.

MODULE 3: CARDIAC PHARMACOLOGY

All Drug Classes, Mechanisms & MCQ Mastery Guide

NEET PG Level | Source: Lippincott's Pharmacology, Goodman & Gilman, Braunwald's Heart Disease

PART 1: ANTIARRHYTHMIC DRUGS - VAUGHAN-WILLIAMS CLASSIFICATION

The Core Framework - Why These Classes Exist

Every arrhythmia is caused by ONE or more of three mechanisms:

Abnormal automaticity (SA node fires too fast, or ectopic focus develops automaticity)
Re-entry (impulse goes around a circuit repeatedly - needs a slow pathway + unidirectional block)
Triggered activity (early or delayed afterdepolarizations)

The four drug classes attack these mechanisms by targeting the ion channels that drive the action potential:

Class	Channel Blocked	Effect on AP	Dominant Effect
I	Na+ (fast)	Slows Phase 0 upstroke	Slows conduction velocity
II	Beta receptors (indirect)	Decreases Phase 4 slope	Slows rate, slows AV node
III	K+ (repolarization)	Prolongs Phase 3, widens AP	Extends refractory period
IV	Ca2+ (L-type)	Slows Phase 4, slows Phase 0 (in nodal tissue)	Slows AV nodal conduction

PART 2: CLASS I - SODIUM CHANNEL BLOCKERS

The Unifying Mechanism

All Class I drugs block the voltage-sensitive fast Na+ channels. They bind to open or inactivated channels (not resting ones). This is use-dependence (or state-dependence): the more frequently a cell fires, the more channels are open or inactivated, and the more drug binds. This means these drugs selectively suppress rapidly firing ectopic cells more than normal cells.

Phase 0 effect: Slower upstroke → slower conduction velocity → widened QRS on ECG

Sub-classification by Action Potential Duration Effect

Sub-class	AP Duration	Kinetics (dissociation from Na+ channel)	Drugs
IA	PROLONGED (also blocks K+)	Intermediate (moderate dissociation)	Quinidine, Procainamide, Disopyramide
IB	SHORTENED (also promotes K+ efflux)	Fast (rapid dissociation)	Lidocaine, Mexiletine, Phenytoin
IC	UNCHANGED	Slow (slow dissociation, greatest Na+ block)	Flecainide, Propafenone

CLASS IA - Quinidine, Procainamide, Disopyramide

Mechanism (Detailed)

Block Na+ channels → slow Phase 0 → widen QRS
ALSO block K+ channels → prolong AP duration → lengthen QT interval (Class III effect)
Together: slow conduction AND extend refractoriness

Drug-by-Drug Differences

Feature	Quinidine	Procainamide	Disopyramide
Route	Oral	IV only (in acute use)	Oral
Alpha blockade	YES - causes vasodilation, reflex tachycardia	No	No
Anticholinergic	Moderate	Minimal	Most anticholinergic
Inotropic effect	Negative (mild)	Negative (mild)	Strongest negative inotropy
Vasoconstriction	No (alpha blocks → vasodilation)	No	YES - peripheral vasoconstriction
Metabolism	Liver (CYP3A4)	Liver → NAPA (active metabolite, Class III)	Liver (CYP3A4) + kidney
Key toxicity	Cinchonism (tinnitus, blurred vision, headache, psychosis); torsades de pointes	Lupus-like syndrome (anti-histone antibodies, reversible on stopping)	Anticholinergic AEs (dry mouth, urinary retention, constipation, blurred vision)
Unique feature	Alpha blockade → hypotension + reflex tachycardia on IV	NAPA accumulates in renal failure → toxicity	Contraindicated in heart failure (strong negative inotrope)

Quinidine Syncope

Quinidine paradoxically can increase ventricular rate in AF before causing conversion to sinus rhythm, because:

It has anticholinergic effects → speeds AV node conduction
It shortens atrial refractory period initially → more impulses reach AV node

This is the "quinidine syncope" or "quinidine paradox" - a famous NEET PG trap.

Procainamide - The Lupus Trap

Long-term use → drug-induced SLE (not true lupus, anti-histone antibodies, NO anti-dsDNA)
Manifests: fever, rash, serositis, arthralgia
Reversible on stopping the drug
More common in slow acetylators (NAPA accumulates less, but parent drug stays longer)

CLASS IB - Lidocaine, Mexiletine, Phenytoin

Mechanism (Detailed)

Block Na+ channels (fast dissociation)
ALSO shorten Phase 3 repolarization → shorter AP duration → shorter QT
Preference for ischemic/depolarized tissue (fast-firing, partially depolarized cells have more inactivated channels → more drug binding)

Key Features

Feature	Lidocaine	Mexiletine	Phenytoin
Route	IV only (extensive first-pass metabolism if oral)	Oral	Oral/IV
Indication	Acute ventricular arrhythmia (especially post-MI), ventricular tachycardia	Chronic ventricular arrhythmias (oral lidocaine substitute)	Digoxin toxicity-induced arrhythmias (unique niche)
Tissue selectivity	Prefers ischemic/depolarized tissue → ideal post-MI	Same	Same, but weaker
AV node effect	Minimal (Class IB drugs spare AV node)	Minimal	Minimal
QT effect	Shortens or no change (unlike IA which prolongs)	Shortens	Shortens
Toxicity	CNS: nystagmus (early marker), drowsiness, slurred speech, seizures, confusion	Nausea, vomiting, CNS (similar to lidocaine), narrow therapeutic index	Gingival hyperplasia, ataxia, nystagmus, teratogenic (fetal hydantoin syndrome)
Special	No negative inotropic effect	No negative inotropic effect	Only antiarrhythmic that is also anticonvulsant

MCQ TRAP: "Why can't lidocaine be given orally?" - Extensive first-pass hepatic metabolism reduces bioavailability to <35%.

MCQ TRAP: "First sign of lidocaine toxicity" - Nystagmus (before more serious CNS symptoms).

CLASS IC - Flecainide, Propafenone

Mechanism (Detailed)

Slowest dissociation from Na+ channels → greatest degree of Na+ blockade
Markedly slow Phase 0 → widest QRS prolongation of all Class I drugs
No significant effect on AP duration → QT stays normal
Propafenone also has beta-blocking and weak Class IV (Ca++ channel blocking) activity

Drugs

Feature	Flecainide	Propafenone
Extra actions	None (pure IC)	Beta-blocker + weak Ca++ block
Indication	AF (in structurally normal hearts), SVT, WPW	Same
Contraindication	Structural heart disease, LVH, HF, post-MI, CAD - proarrhythmic death (CAST trial)	Same
QRS effect	Marked widening	Widening
AE	Blurred vision, proarrhythmia	Metallic taste, bronchospasm (beta-block), proarrhythmia

CAST Trial - The Most Important Pharmacology Trial in Cardiology

The Cardiac Arrhythmia Suppression Trial (CAST, 1989) tested whether suppressing PVCs after MI (with encainide, flecainide, moricizine) reduced mortality.

Result: These drugs INCREASED mortality despite suppressing PVCs. Death rate doubled.

Lesson: Asymptomatic PVCs after MI should NOT be treated with Class IC drugs. The arrhythmia is a marker, not the cause of death. Treating the marker does not help and may kill.

Class IC drugs are now used ONLY in structurally normal hearts.

PART 3: CLASS II - BETA-BLOCKERS

Core Mechanism

Beta-1 receptor blockade → decreased cAMP → decreased PKA activity → decreased If current (funny current) in SA node → flattened Phase 4 slope → slower automaticity

Net cardiac effects:

Negative chronotropy - slows heart rate (SA node)
Negative dromotropy - slows AV conduction, prolonged PR
Negative inotropy - reduced contractility
Anti-ischemic - reduced myocardial O2 demand

Beta-Blocker Classification

Property	Selective (β1)	Non-Selective (β1 + β2)
Drugs	Metoprolol, atenolol, bisoprolol, nebivolol	Propranolol, carvedilol, labetalol, sotalol (in part)
Safe in asthma?	Relatively safer (less β2 blockade)	CONTRAINDICATED
Peripheral vascular effects	Less vasoconstriction	More vasoconstriction (blocks β2-mediated vasodilation)

Alpha + Beta Blockers

Drug	Beta	Alpha	Special Feature
Carvedilol	β1 + β2 (non-selective)	α1	Antioxidant; used in HFrEF, post-MI
Labetalol	β1 + β2 (non-selective)	α1	IV use in hypertensive emergencies, safe in pregnancy
Nebivolol	β1 (selective)	None	Also releases NO (vasodilatory)

Beta-Blocker Drug Comparisons - The NEET PG Favorites

Drug	Selectivity	Special Property	Key Use
Propranolol	Non-selective (β1+β2)	First beta-blocker; lipophilic (CNS penetration)	Arrhythmias, HTN, tremor, migraine, thyroid storm, anxiety
Metoprolol	β1-selective	Most used in cardiology; metabolized by CYP2D6	Acute MI, HFrEF, arrhythmias, HTN
Atenolol	β1-selective	Least CNS penetration (hydrophilic)	HTN (less favored now - ASCOT trial)
Bisoprolol	β1-selective (highest)	Most selective; lowest bronchospasm risk	HFrEF (proven mortality benefit), HTN
Carvedilol	Non-selective + α1	Antioxidant; reduces remodeling	HFrEF (proven mortality benefit), post-MI
Esmolol	β1-selective	Ultra-short acting (half-life 9 min, broken down by plasma esterases)	Perioperative tachycardia, acute SVT, aortic dissection
Sotalol	Non-selective β (+ Class III)	Also blocks K+ channels → prolongs QT	AF, ventricular arrhythmias; monitor QT
Labetalol	Non-selective β + α1	IV form available	Hypertensive emergency in pregnancy, aortic dissection

Beta-Blocker Adverse Effects - ALL Mechanisms Explained

Adverse Effect	Drug	Mechanism
Bradycardia	All	Reduced SA node automaticity
AV block	All	Reduced AV nodal conduction
Bronchospasm	Non-selective (propranolol)	β2 block → bronchoconstriction
Cold extremities	All (worse non-selective)	β2 block → loss of vasodilatory tone
Fatigue	All	Reduced cardiac output, CNS effects
Masked hypoglycemia	All (especially non-selective)	β2 block → blunts tachycardia (warning sign); sweating persists
Impotence	All	Reduced penile blood flow
Worsening HF (acutely)	All	Negative inotropy (start low, go slow in HFrEF)
Dyslipidemia	All	Increased TGs, reduced HDL
CNS effects	Lipophilic (propranolol, metoprolol)	Cross blood-brain barrier → nightmares, depression, hallucinations
Rebound hypertension	All (if stopped abruptly)	Upregulation of beta receptors during therapy

Absolute Contraindications to Beta-Blockers

Uncompensated severe asthma / bronchospasm
Cardiogenic shock
High-degree AV block (2nd degree Mobitz II, 3rd degree) without pacemaker
Sinus node dysfunction without pacemaker
Severe bradycardia (<50/min)

MCQ TRAP: Beta-blockers are NOT contraindicated in controlled mild asthma/COPD (use cardioselective ones with caution). They are contraindicated in SEVERE / uncontrolled bronchospasm.

PART 4: CLASS III - POTASSIUM CHANNEL BLOCKERS

Core Mechanism

Block delayed rectifier K+ channels (IKr) → delay Phase 3 repolarization → prolong AP duration → prolong QT interval → prolong ERP

Effect: Cells remain refractory longer → breaks re-entry circuits

The Class III Drugs

Amiodarone - "The Drug of All Classes"

Mechanism: Has ALL FOUR Vaughan-Williams actions:

Class I: Na+ channel block (slow conduction)
Class II: Beta-receptor block (slows SA/AV nodes)
Class III: K+ channel block (prolongs AP, QT) - DOMINANT effect
Class IV: Ca2+ channel block
PLUS: Alpha-adrenergic blockade (vasodilation)

Pharmacokinetics:

Oral bioavailability: ~50% (incomplete, variable)
Half-life: 40-55 days (weeks to months - the longest of any drug)
Volume of distribution: extremely large (tissues including fat, lung, liver)
Metabolized by: CYP3A4 (substrate); inhibits CYP1A2, CYP2C9, CYP2D6, P-glycoprotein
Clinical onset after oral dose: weeks to months (loading doses required to accelerate)

Amiodarone Adverse Effects - The Most Tested List in Pharmacology

System	Adverse Effect	Notes
Thyroid	Hypo OR hyperthyroidism	Contains 37% iodine by weight; iodine load causes Wolff-Chaikoff effect (hypothyroid) OR releases excess T4 (hyperthyroid = Jod-Basedow)
Lung	Pulmonary fibrosis/pneumonitis	Most dangerous; check CXR + PFTs regularly; if develops → stop drug
Liver	Hepatotoxicity	Elevated LFTs; rarely cirrhosis
Eye	Corneal microdeposits	Near-universal with long-term use; rarely cause vision loss; also optic neuritis
Skin	Blue-grey discoloration + photosensitivity	Direct iodine deposition; use sunscreen
Neuro	Peripheral neuropathy, tremor, ataxia
ECG	Prolongs QT (but low torsades risk despite QT prolongation - "antiarrhythmic paradox")
Sinus node	Sinus bradycardia	Class II + IV effects
Thyroid (screening)	Check TFTs before, at 3-6 months, and every 6 months

Drug Interactions (from CYP inhibition):

Increases digoxin levels (inhibits P-gp + CYP)
Increases warfarin effect (inhibits CYP2C9) - reduce warfarin dose by 30-50%
Increases simvastatin/cyclosporine/phenytoin levels

MCQ TRAP: "Amiodarone prolongs QT but rarely causes torsades de pointes" - this is because it ALSO blocks ICaL (Ca2+ channels), which protects against early afterdepolarizations (the trigger for torsades). It is the LEAST proarrhythmic of Class I and III drugs.

Dronedarone

Amiodarone derivative WITHOUT iodine
Shorter half-life (~24 hours)
No thyroid toxicity (no iodine)
Less effective than amiodarone
Contraindicated in: Permanent AF, symptomatic HF, severe LV dysfunction (increases mortality in these groups)
Used for: Paroxysmal/persistent AF in structurally normal or mild structural disease

Sotalol

Class III + non-selective beta-blocker (dual mechanism)
l-isomer: beta-blocking activity
d-isomer: K+ channel block (Class III)
Blocks IKr → prolongs QT → risk of torsades de pointes
Used for: AF maintenance, ventricular arrhythmias (especially in LVH/CAD)
Initiation must be inpatient (QT monitoring)
Renally eliminated → dose reduce in renal failure

Dofetilide

Pure IKr blocker (no beta-block, no other effects)
Used in AF/flutter with heart failure or CAD (safe in structural disease - no negative inotropy)
Must be initiated in hospital (risk of torsades)
Renally excreted → contraindicated with drugs that block tubular secretion (verapamil, cimetidine, trimethoprim)

Ibutilide

Mixed: K+ channel block + activates inward Na+ current (Class IA-like + III)
IV only - drug of choice for acute chemical cardioversion of atrial flutter
Risk of torsades → must monitor in hospital
Extensive first-pass → no oral form

PART 5: CLASS IV - CALCIUM CHANNEL BLOCKERS (NON-DIHYDROPYRIDINE)

Core Mechanism

Block L-type (long-lasting) voltage-gated Ca2+ channels. In nodal tissue (SA and AV), Phase 0 and Phase 4 are Ca2+-dependent. Blockade → slows SA node automaticity + slows AV nodal conduction.

Key distinction: Only non-dihydropyridines (NDHPs) are Class IV antiarrhythmics. Dihydropyridines (amlodipine, nifedipine) mainly dilate peripheral vessels - minimal cardiac effect.

Verapamil vs Diltiazem vs Dihydropyridines

Feature	Verapamil	Diltiazem	Amlodipine/Nifedipine (DHP)
Class	Class IV (cardiac dominant)	Class IV (cardiac + vascular)	Not antiarrhythmic
Heart rate	Decreases	Decreases	Reflex INCREASE (vasodilation)
AV nodal conduction	Strongest slowing	Moderate slowing	No effect
Vasodilation	Moderate	Moderate	Most potent
Negative inotropy	Strongest	Moderate	Minimal
Use in HFrEF	CONTRAINDICATED	CONTRAINDICATED	Amlodipine: safe
Metabolism	CYP3A4 + P-gp inhibitor	CYP3A4 + P-gp inhibitor	CYP3A4 substrate
Key indication	SVT termination, AF rate control, AVNRT	Same; also angina	Angina, HTN, Raynaud's
Special	Do NOT combine with beta-blockers (additive AV block + bradycardia)	Same	Safe with beta-blockers

MCQ TRAP: "Which calcium channel blocker is safe to use with beta-blockers?"

Amlodipine (DHP) - safe combination
Verapamil + beta-blocker = DANGEROUS → risk of complete heart block + cardiac arrest
Diltiazem + beta-blocker = AVOID (less dangerous than verapamil but still risky)

PART 6: CARDIAC GLYCOSIDES - DIGOXIN

Mechanism - Step by Step

Step 1: Digoxin inhibits Na+/K+ ATPase (the sodium pump) on cardiac myocytes

Step 2: Na+ accumulates inside the cell (pump is blocked, can't push Na+ out)

Step 3: The Na+/Ca2+ exchanger (NCX) normally exports Ca2+ using the Na+ gradient. With high intracellular Na+, the gradient is reduced → NCX exports LESS Ca2+

Step 4: Intracellular Ca2+ rises → SR releases more Ca2+ → stronger actin-myosin cross-bridges → Positive inotropy (increased contractility)

The Vagal Mechanism (for rate control):

Digoxin also has parasympathomimetic (vagal) effects → slows SA node + AV nodal conduction
This is how it controls ventricular rate in AF
This effect is ABOLISHED by atropine (vagal block) and worsened by hypokalemia

ECG Effects of Digoxin (Therapeutic vs Toxic)

Effect	ECG Finding	Notes
Therapeutic	"Reverse tick" or "Salvador Dali moustache" ST depression	Scooped/down-sloping ST depression (not ischemia)
Therapeutic	Shortened QT
Therapeutic	Prolonged PR (AV nodal slowing)
Toxic	Virtually ANY arrhythmia	Most famous: Bidirectional VT + AV blocks
Toxic	Bradyarrhythmias (sinus bradycardia, AV blocks)	Via vagal excess
Toxic	PAT (Paroxysmal Atrial Tachycardia) with block	Classic: tachycardia + AV block = digoxin toxicity
Toxic	Bigeminy, trigeminy	PVCs from enhanced automaticity

Digoxin Toxicity - Causes and Recognition

Predisposing Factors (that increase toxicity risk)

Factor	Mechanism
Hypokalemia	K+ and digoxin COMPETE for Na+/K+ ATPase binding site. Low K+ → more digoxin binding → enhanced toxicity. MOST COMMON cause of toxicity.
Hypomagnesemia	Lowers threshold for arrhythmias
Hypothyroidism	Reduces renal clearance of digoxin
Renal failure	Digoxin renally excreted → accumulates
Elderly	Reduced renal function + lower muscle mass → less volume of distribution
Amiodarone	Inhibits P-glycoprotein → increases digoxin levels
Verapamil	Same mechanism → increases digoxin levels
Quinidine	Displaces digoxin from tissue binding + inhibits renal tubular secretion → doubles digoxin level

Digoxin Toxicity Symptoms

System	Symptoms
GI	Nausea, vomiting, anorexia (earliest symptoms)
CNS	Headache, confusion, xanthopsia (objects appear yellow-green), visual halos
Cardiac	Virtually any arrhythmia: VT (especially bidirectional), AV blocks, PAT with block, VF

Treatment of Digoxin Toxicity

Stop digoxin
Correct hypokalemia/hypomagnesemia
Digoxin-specific antibody fragments (Fab) - Digibind/DigiFab - definitive antidote
Atropine for bradyarrhythmias
Lidocaine or phenytoin for ventricular arrhythmias (NOT quinidine - it increases digoxin levels; NOT cardioversion if avoidable - can precipitate VF)

MCQ TRAP: "The antidote to digoxin toxicity" = Digoxin-specific Fab antibody fragments (NOT atropine, NOT potassium alone, NOT lidocaine).

PART 7: OTHER ESSENTIAL CARDIAC DRUGS

Adenosine

Feature	Detail
Mechanism	Activates A1 adenosine receptors → opens K+ channels (IKAch) → hyperpolarizes SA and AV nodes → profound transient AV block
Indication	Drug of choice for acute termination of AVNRT and AVRT (narrow complex SVT)
Dose	6 mg IV rapid push; if no response → 12 mg; repeat 12 mg
Route	Must be given as rapid IV push (followed by flush) due to half-life of <10 seconds
Half-life	8-10 seconds (metabolized by red blood cells + endothelium)
Adverse effects	Flushing, chest tightness, dyspnea, transient complete AV block/asystole (brief, seconds) - patients must be warned
Contraindications	2nd or 3rd degree AV block (without pacemaker), sick sinus syndrome, asthma/bronchospasm (can cause bronchospasm via A2 receptors)
Drug interaction	Theophylline blocks adenosine receptors → antagonist (reduces effect)
	Dipyridamole blocks adenosine deaminase → potentiates effect (reduce dose)
Does NOT work in	Ventricular tachycardia, atrial flutter, AF (these are not AV node-dependent)
Diagnostic use	If adenosine terminates SVT = AV node-dependent (AVNRT, AVRT); if not terminated but rate slows transiently = atrial flutter or AF

MCQ TRAP: "Drug of choice for AVNRT" = Adenosine (for acute termination). If adenosine fails or contraindicated → verapamil or diltiazem. For long-term prevention → beta-blocker or CCB; ablation is curative.

Atropine

Feature	Detail
Mechanism	Muscarinic (M2) receptor antagonist → blocks vagal effect on SA and AV nodes → increases SA node automaticity + speeds AV conduction
Indication	Sinus bradycardia, AV nodal block (Mobitz I), vagally-mediated bradycardia
Dose	0.5-1 mg IV (minimum 0.5 mg - paradoxical bradycardia with smaller doses due to CNS vagal stimulation)
Does NOT work in	Infranodal block (His-Purkinje) - no autonomic innervation there; Digoxin toxicity bradycardia may partially respond
Adverse effects	Tachycardia, dry mouth, urinary retention, mydriasis, confusion (anticholinergic)

Isoprenaline (Isoproterenol)

Feature	Detail
Mechanism	Non-selective beta-1 + beta-2 agonist → increases SA node rate, speeds AV conduction, positive inotropy
Cardiac use	Temporary bridge for complete heart block (while awaiting pacemaker), torsades de pointes (increases rate → shortens QT → suppresses torsades)
Adverse	Tachycardia, arrhythmias, hypotension (vasodilation via beta-2)

PART 8: DRUGS FOR HEART FAILURE

ACE Inhibitors

Feature	Detail
Mechanism	Block ACE → prevent Angiotensin I → Angiotensin II conversion; ALSO prevent bradykinin degradation → bradykinin accumulates
Cardiac effects	Reduced preload + afterload; reverse cardiac remodeling; reduce aldosterone
Indication	HFrEF (proven mortality benefit), post-MI, HTN, diabetic nephropathy, CKD
Key drugs	Ramipril, enalapril, captopril, lisinopril, perindopril
Cough	Dry cough (most common reason for stopping) - due to bradykinin + substance P accumulation
Angioedema	Life-threatening; bradykinin-mediated; contraindication to restart ACE inhibitor
Contraindications	Pregnancy (fetotoxic, teratogenic), bilateral renal artery stenosis (will precipitate acute renal failure), angioedema history, hyperkalemia
Drug interaction	NSAIDs reduce efficacy; K+ supplements/spironolactone → hyperkalemia
Captopril unique AE	Agranulocytosis (rare but serious) - also contains sulfhydryl group → rash

ARBs (Angiotensin Receptor Blockers)

Feature	Detail
Mechanism	Block AT1 receptor (not ACE) → prevent Ang II effect without affecting bradykinin
Key advantage	No cough (bradykinin not affected) - used when ACE inhibitors not tolerated
Drugs	Losartan, valsartan, candesartan, telmisartan, irbesartan
Indications	Same as ACE inhibitors (HFrEF, HTN, post-MI, diabetic nephropathy)
Contraindications	Same as ACE inhibitors (pregnancy, bilateral RAS, angioedema - though less common)
ACE+ARB combination	AVOIDED - dual RAAS blockade increases hyperkalemia + renal failure without additional benefit (ONTARGET trial)

ARNi - Sacubitril/Valsartan (Entresto)

Feature	Detail
Mechanism	Sacubitril inhibits neprilysin → prevents degradation of BNP, ANP → increased natriuresis + vasodilation; combined with valsartan (AT1 block)
Indication	HFrEF (EF <40%) - superior to ACE inhibitor (PARADIGM-HF trial - reduced mortality vs enalapril)
Contraindication	Cannot use with ACE inhibitor (washout period of 36 hours needed to avoid angioedema)
Key point	Must discontinue ACE inhibitor ≥36 hours before starting

Nitrates

Drug	Route	Duration	Main Use
GTN (Glyceryl trinitrate)	Sublingual tablet/spray	5-10 min	Acute angina relief
Isosorbide dinitrate (ISDN)	Oral/IV	Intermediate	Angina prophylaxis
Isosorbide mononitrate (ISMN)	Oral	Long-acting	Angina prophylaxis
IV nitroglycerin	IV infusion	Minutes	Hypertensive emergency, acute heart failure, NSTEMI

Mechanism: Converted to nitric oxide (NO) → activates guanylate cyclase → increased cGMP → smooth muscle relaxation → venodilation (reduces preload primarily) + mild arterial dilation

Tolerance: Nitrate tolerance develops with continuous use → eccentric dosing (nitrate-free interval of 8-12 hours per day)

Contraindication: PDE5 inhibitors (sildenafil, tadalafil) - both increase cGMP → profound hypotension → absolute contraindication (within 24 hours for sildenafil, 48 hours for tadalafil)

MCQ TRAP: "Why do nitrates cause headache?" - NO causes cerebral vasodilation → headache. This is a sign the drug is working. Treat with paracetamol.

Diuretics in Cardiac Practice

Drug	Class	Mechanism	Key Cardiac Use	Electrolyte Effect
Furosemide	Loop (Henle)	Block Na+/K+/2Cl- cotransporter	Acute pulmonary edema, HF, HTN	Hypokalemia, hypomagnesemia, hyperuricemia
Spironolactone	Aldosterone antagonist	Block mineralocorticoid receptor	HFrEF (proven mortality benefit), resistant HTN, Conn's syndrome	Hyperkalemia + hyponatremia; gynecomastia
Eplerenone	Selective aldosterone antagonist	Selective MR block (no sex hormone effects)	Post-MI HFrEF (EPHESUS trial)	Hyperkalemia; no gynecomastia
Thiazides	DCT	Block Na+/Cl- cotransporter	Mild HTN, HF (mild), edema	Hypokalemia, hyperuricemia, hyperglycemia, hypercalcemia
Acetazolamide	Carbonic anhydrase inhibitor	-	Altitude sickness, metabolic alkalosis	Metabolic acidosis

Spironolactone MCQ Trap: RALES trial showed spironolactone reduces mortality in severe HFrEF. EPHESUS showed eplerenone reduces mortality post-MI with HF. But BOTH can cause life-threatening hyperkalemia - check K+ levels.

Statins in Cardiac Practice

Feature	Detail
Mechanism	Inhibit HMG-CoA reductase → less cholesterol synthesis → upregulate LDL receptors → LDL cleared from blood
Primary effect	Lower LDL cholesterol (up to 50-60% with high-intensity statins)
Pleiotropic effects	Plaque stabilization, anti-inflammatory, antiplatelet, endothelial function improvement
High-intensity statins	Atorvastatin 40-80 mg, Rosuvastatin 20-40 mg
Indication	Post-ACS (regardless of baseline LDL), CAD, diabetes, high CV risk
Adverse effects	Myopathy/myalgia (most common), rhabdomyolysis (rare, especially with fibrate combination), elevated LFTs, new-onset diabetes
Contraindications	Pregnancy, active liver disease
Drug interaction	Gemfibrozil + statin = rhabdomyolysis risk (inhibits CYP450 metabolism of statins)

PART 9: ANTIPLATELET AND ANTICOAGULANT DRUGS

Antiplatelet Drugs

Drug	Mechanism	Key Use	Key AE
Aspirin	Irreversible COX-1 inhibition → no thromboxane A2 synthesis	ACS, post-MI, post-stent, AF, stroke prevention (cardioembolic)	GI bleeding, aspirin-exacerbated asthma
Clopidogrel	Irreversible P2Y12 receptor block (ADP receptor) - prodrug, needs CYP2C19	ACS, post-stent (DAPT)	Poor response in CYP2C19 poor metabolizers; bleeding
Ticagrelor	Reversible P2Y12 block (NOT a prodrug, faster onset)	ACS (PLATO trial - superior to clopidogrel)	Dyspnea (unique - bradykinin effect), bleeding
Prasugrel	Irreversible P2Y12 (more potent, faster than clopidogrel)	ACS with PCI (TRITON trial)	Contraindicated in: prior stroke/TIA, age >75, weight <60 kg (excess bleeding)

MCQ TRAP: "Ticagrelor vs Clopidogrel"

Ticagrelor: reversible (off in 3-5 days vs 7-10 days for clopidogrel), direct acting (no CYP2C19 needed), superior outcomes in ACS
Clopidogrel: irreversible, prodrug (CYP2C19 needed), cheaper, used in stroke patients

Anticoagulants in Cardiology

Drug	Mechanism	Key Cardiac Use	Reversal
Heparin (UFH)	Activates antithrombin III → inhibits IIa (thrombin) + Xa	Acute ACS, PE, DVT, AF cardioversion (bridging), procedures	Protamine sulfate
LMWH (Enoxaparin)	Activates ATIII → mostly anti-Xa	ACS (NSTEMI/STEMI), DVT prophylaxis	Partial reversal with protamine
Warfarin	Inhibits Vitamin K epoxide reductase → blocks synthesis of II, VII, IX, X, Protein C, S	AF (chronic), mechanical valves, DVT/PE	Vitamin K (slow) or FFP/PCC (rapid); INR monitoring
Dabigatran	Direct thrombin (IIa) inhibitor	AF (stroke prevention), DVT/PE, VTE	Idarucizumab (Praxbind)
Rivaroxaban/Apixaban	Direct factor Xa inhibitors	AF, DVT/PE, ACS (rivaroxaban)	Andexanet alfa (for Xa inhibitors)

Heparin-Induced Thrombocytopenia (HIT):

Usually 5-10 days after heparin initiation
Paradoxically causes THROMBOSIS (not just bleeding) - HIT antibodies activate platelets
Treatment: STOP heparin + start non-heparin anticoagulant (argatroban, fondaparinux, bivalirudin)
Do NOT give warfarin in acute HIT (can worsen thrombosis via protein C depletion)
Do NOT give platelet transfusion (adds fuel to fire)

PART 10: NEET PG MCQs - PROGRESSIVE DIFFICULTY

Level 1 - Foundation

Q1. The mechanism of antiarrhythmic action of lidocaine is:

A. K+ channel block
B. Beta-receptor block
C. Na+ channel block + shortening of AP duration
D. Ca2+ channel block

Answer: C

Why: Lidocaine = Class IB. Na+ channel block (slows Phase 0) + ALSO shortens AP duration (hastens Phase 3 repolarization by promoting K+ efflux). This distinguishes it from Class IA (prolongs AP) and IC (no change to AP).

Why A is wrong: K+ block = Class III (amiodarone, sotalol, dofetilide). Why B is wrong: Beta block = Class II. Why D is wrong: Ca2+ block = Class IV (verapamil, diltiazem).

Q2. Drug-induced lupus with anti-histone antibodies is a well-known side effect of:

A. Amiodarone
B. Quinidine
C. Procainamide
D. Disopyramide

Answer: C - Procainamide

Why: Procainamide is acetylated in the liver to NAPA. The parent drug (not NAPA) causes lupus-like syndrome with anti-histone antibodies. More common in slow acetylators. Key features: fever, arthralgia, serositis, positive ANA - but NO renal or CNS involvement (unlike true SLE) and anti-dsDNA is NEGATIVE.

Why B is wrong: Quinidine causes cinchonism, not lupus. Why A is wrong: Amiodarone causes thyroid, pulmonary, and corneal effects.

Q3. A patient with AF develops junctional tachycardia at 130/min with 2:1 AV block. The most likely cause is:

A. Theophylline toxicity
B. Digoxin toxicity
C. Beta-blocker overdose
D. Verapamil toxicity

Answer: B - Digoxin toxicity

Why: PAT (Paroxysmal Atrial Tachycardia) with block is pathognomonic for digoxin toxicity. The enhanced automaticity creates the tachycardia, while the vagal/AV node slowing creates the block. The combination is characteristic.

Why C and D are wrong: Beta-blockers and verapamil cause bradyarrhythmias, not tachyarrhythmias.

Level 2 - Applied

Q4. A 58-year-old male with a history of anterior MI and reduced EF (30%) presents with symptomatic PVCs. Which drug is MOST appropriate?

A. Flecainide
B. Quinidine
C. Amiodarone
D. Propafenone

Answer: C - Amiodarone

Why: The CAST trial showed Class IC drugs (flecainide, propafenone) INCREASE mortality in patients with structural heart disease (post-MI, reduced EF). Class IA drugs (quinidine) also increase mortality in this setting. Amiodarone, despite its toxicity profile, is the LEAST proarrhythmic option in structural heart disease.

Why A and D are wrong: CAST trial - Class IC drugs are contraindicated in structural heart disease. Why B is wrong: Quinidine also proarrhythmic in structural heart disease.

Q5. Which adverse effect of amiodarone is NOT related to its iodine content?

A. Hypothyroidism
B. Hyperthyroidism
C. Corneal microdeposits
D. Blue-gray skin discoloration

Answer: C - Corneal microdeposits

Why: Corneal deposits are due to direct tissue deposition of the amiodarone molecule itself, not the iodine content. Thyroid effects (hypo and hyper) are both iodine-related (Wolff-Chaikoff effect and Jod-Basedow phenomenon). Skin discoloration involves both iodine deposition and direct drug accumulation.

Q6. A patient with known AF is being started on digoxin for rate control. He is also on amiodarone. What adjustment is required?

A. No adjustment needed
B. Increase digoxin dose
C. Reduce digoxin dose by approximately 50%
D. Switch to a different rate-control agent

Answer: C

Why: Amiodarone inhibits P-glycoprotein (reduces renal tubular secretion of digoxin) AND inhibits CYP enzymes involved in digoxin metabolism. This roughly doubles digoxin levels. The dose must be reduced by ~50% and levels monitored. Same interaction occurs with verapamil and quinidine.

Q7. The drug of choice for acute termination of AVNRT in a hemodynamically stable patient is:

A. Lidocaine IV
B. Amiodarone IV
C. Adenosine IV
D. Digoxin IV

Answer: C - Adenosine

Why: AVNRT depends on the AV node as part of its re-entry circuit. Adenosine transiently blocks the AV node → breaks the circuit → terminates the tachycardia. Half-life of <10 seconds makes it safe for acute use.

Why A is wrong: Lidocaine is for ventricular arrhythmias (Class IB - poor effect on AV node). Why B is wrong: IV amiodarone is reserved for refractory or recurrent SVT or VT; not first-line. Why D is wrong: Digoxin acts too slowly for acute termination; its ventricular rate slowing in AF is useful chronically but inappropriate here for acute termination.

Level 3 - High Difficulty / Integration

Q8. A 45-year-old woman has paroxysmal AF and wants rhythm control. She has no structural heart disease. Which of the following is MOST appropriate for long-term maintenance of sinus rhythm?

A. Amiodarone
B. Digoxin
C. Flecainide (as "pill-in-pocket")
D. Sotalol

Answer: C - Flecainide

Why: In structurally normal heart AF, Class IC drugs (flecainide) are the PREFERRED rhythm control agents due to their efficacy and relative safety (no structural disease = no CAST-like risk). "Pill-in-pocket" (taking flecainide only when an episode starts) is a validated approach in paroxysmal AF.

Why A is wrong: Amiodarone is the most effective antiarrhythmic but its toxicity profile (thyroid, lung, liver, cornea) makes it a LAST RESORT - not first-line in a young woman with no structural disease. Why B is wrong: Digoxin is a rate-control drug, not rhythm control. Why D is wrong: Sotalol is an option but requires QT monitoring and is less preferred than flecainide in a normal-heart patient.

Q9. A patient with HFrEF on enalapril develops a dry, non-productive cough. The BEST next step is:

A. Add an antihistamine for the cough
B. Reduce the dose of enalapril
C. Switch to an ARB (e.g., losartan)
D. Switch to a beta-blocker

Answer: C - Switch to ARB

Why: ACE inhibitor cough is caused by bradykinin accumulation (ACE normally degrades bradykinin). ARBs block the AT1 receptor but do NOT affect ACE → bradykinin is still broken down normally → NO cough. Switching to an ARB maintains equivalent cardiovascular protection without cough.

Why A is wrong: This is a pharmacological mechanism-based cough, not allergy - antihistamines won't help. Why B is wrong: Dose reduction rarely eliminates ACE cough (it's a class effect).

Q10. Which of the following is the mechanism by which hypokalemia worsens digoxin toxicity?

A. Hypokalemia increases the rate of renal excretion of digoxin
B. K+ and digoxin compete for the same binding site on Na+/K+ ATPase
C. Hypokalemia decreases myocardial contractility
D. Hypokalemia shortens the action potential, allowing more digoxin binding

Answer: B - Competition for Na+/K+ ATPase binding site

Why: K+ and digoxin bind to the SAME site on the Na+/K+ ATPase (the extracellular K+-binding site). When plasma K+ is LOW, there is LESS competition → digoxin binds MORE effectively → greater pump inhibition → greater intracellular Na+ and Ca2+ rise → enhanced toxicity. This is why treating hypokalemia is the FIRST step in managing digoxin toxicity.

Why A is wrong: Hypokalemia does not increase digoxin excretion - it increases digoxin BINDING. Why C is wrong: Hypokalemia actually increases excitability of myocardial cells (predisposing to arrhythmias), not decreased contractility.

QUICK-FIRE ONE-LINERS

Class IA = Na+ block + K+ block = prolongs QT (Quinidine, Procainamide, Disopyramide)
Class IB = Na+ block + shortens AP = used in ventricular arrhythmias (Lidocaine, Mexiletine)
Class IC = Na+ block only = widest QRS, CAST trial, contraindicated in structural HD (Flecainide, Propafenone)
Class II = Beta block = negative chrono-dromo-inotropy (Metoprolol, Propranolol, Esmolol)
Class III = K+ block = prolongs QT, prolongs ERP (Amiodarone, Sotalol, Dofetilide)
Class IV = Ca2+ block (non-DHP) = AV nodal slowing (Verapamil, Diltiazem)
Amiodarone = "everything" = Class I+II+III+IV + alpha block; longest half-life (40-55 days)
Amiodarone + warfarin = increase bleeding risk (reduce warfarin dose 30-50%)
Amiodarone + digoxin = increase digoxin toxicity (reduce digoxin dose 50%)
Quinidine + digoxin = doubles digoxin level (2 mechanisms: displaces from tissue + blocks renal secretion)
Procainamide = lupus-like syndrome, anti-histone, ANA positive, anti-dsDNA negative
Disopyramide = most anticholinergic, most negative inotropic of Class IA
Cinchonism = quinidine toxicity (tinnitus, blurred vision, psychosis)
Lidocaine first toxicity sign = nystagmus (CNS)
Lidocaine given IV only = first-pass liver metabolism if oral
CAST trial = Class IC drugs increase mortality post-MI
Sotalol = Class II + III; monitor QT; renally eliminated
Dofetilide = pure Class III; for AF in HF/CAD; inpatient initiation; renal excretion
Ibutilide = IV only; chemical cardioversion of atrial flutter
Adenosine = half-life <10 seconds; drug of choice for AVNRT/AVRT; blocked by theophylline
Digoxin mechanism = inhibits Na/K ATPase → indirect Ca2+ rise → inotropy
Digoxin toxicity = PAT with block (pathognomonic); bidirectional VT; any arrhythmia
Digoxin antidote = Fab antibody fragments (Digibind)
Hypokalemia = commonest cause of digoxin toxicity
Verapamil + beta-blocker = CONTRAINDICATED (complete heart block risk)
ACE inhibitor cough = bradykinin accumulation → switch to ARB
Angioedema = ACE inhibitor (bradykinin-mediated) → switch to ARB (but avoid if history of angioedema - ARBs can also rarely cause it)
Nitrates + sildenafil = absolute contraindication (hypotension)
HIT = stop heparin + anticoagulate with argatroban; NO warfarin acutely; NO platelet transfusion
CAST trial = Class IC proarrhythmic in structural HD
RALES = spironolactone reduces mortality in severe HFrEF
PARADIGM-HF = sacubitril/valsartan superior to enalapril in HFrEF

DRUG LOOK-ALIKE / SOUND-ALIKE TABLE

Drug 1	Drug 2	Key Difference
Quinidine (Class IA)	Quinine (antimalarial)	Similar structure but different uses; both cause cinchonism
Verapamil (Class IV, cardiac > vessel)	Amlodipine (DHP, vessel > cardiac)	Verapamil slows AV node; Amlodipine causes reflex tachycardia
Sotalol (Class II+III)	Atenolol (Class II only)	Sotalol ALSO has Class III; prolongs QT; atenolol does NOT
Propafenone (Class IC + beta)	Propranolol (Class II only)	Propafenone also has Na+ block + weak Ca++ block
Dofetilide (pure K+ block)	Dronedarone (I+II+III+IV, no iodine)	Dofetilide = renally excreted pure Class III; Dronedarone = amiodarone without iodine
Adenosine (AV nodal block)	Atropine (AV nodal unblock)	Opposite effects on AV node - adenosine terminates SVT; atropine treats bradycardia
Ibutilide (AF flutter → cardioversion)	Dofetilide (AF maintenance)	IV vs Oral; Ibutilide is acute, dofetilide is chronic
Clopidogrel (prodrug, CYP2C19)	Ticagrelor (direct, reversible)	Ticagrelor needs no activation, reversible, superior in ACS (PLATO)

Module 3 complete. The entire Vaughan-Williams classification, key cardiac drugs, mechanisms, adverse effects, drug interactions, and NEET PG-style MCQs are covered.

Next modules available:

Module 4: Investigations - Echo, troponin, BNP, stress testing, catheterization
Module 5: Hypertension - Classification, guidelines, resistant HTN, hypertensive emergencies, secondary HTN
Module 6: Arrhythmias - AF, flutter, SVT types, WPW, VT, VF, all treatment algorithms

Which is next?

This is a shared conversation. Sign in to Orris to start your own chat.